SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ASN'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BU5_B_RBFB302_1
(PROTEIN (FLAVODOXIN))		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		4 / 8 THR A  16
ASN A 362
ASP A 397
TYR A 350
 THR  A  16 ( 0.8A)
ASN  A 362 ( 0.6A)
ASP  A 397 ( 0.6A)
TYR  A 350 ( 1.3A)
 1.03A 1bu5B-4kqnA:
undetectable		 1bu5B-4kqnA:
16.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C8L_A_CFFA940_1
(PROTEIN (GLYCOGEN
PHOSPHORYLASE))		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.08A 1c8lA-1omoA:
undetectable		 1c8lA-1omoA:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DZM_A_BZMA600_0
(ODORANT-BINDING
PROTEIN)		 4jbe GAMMA-GLUTAMYL
PHOSPHATE REDUCTASE
(Saccharomonospor
a
viridis) 		4 / 8 ILE A 205
ASN A 144
GLY A 122
LEU A 148
 ILE  A 205 ( 0.7A)
ASN  A 144 ( 0.6A)
GLY  A 122 ( 0.0A)
LEU  A 148 ( 0.5A)
 0.98A 1dzmA-4jbeA:
undetectable		 1dzmA-4jbeA:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7C_A_HLTA4007_1
(SERUM ALBUMIN)		 2qvs CAMP-DEPENDENT
PROTEIN KINASE TYPE
II-ALPHA REGULATORY
SUBUNIT
(Mus
musculus) 		4 / 8 ASN B 240
ASP B 140
LEU B 144
LEU B 139
 ASN  B 240 ( 0.6A)
ASP  B 140 ( 0.5A)
LEU  B 144 ( 0.6A)
LEU  B 139 ( 0.6A)
 1.00A 1e7cA-2qvsB:
undetectable		 1e7cA-2qvsB:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FXV_B_PNNB1001_0
(PENICILLIN ACYLASE)		 5k66 NTA1P
(Saccharomyces
cerevisiae) 		4 / 7 PHE A  64
SER A 187
ALA A 221
PHE A 401
 None
ASN  A 501 (-2.9A)
ASN  A 501 (-4.1A)
None
 1.19A 1fxvA-5k66A:
undetectable
1fxvB-5k66A:
undetectable		 1fxvA-5k66A:
17.48
1fxvB-5k66A:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GFZ_A_CFFA940_1
(GLYCOGEN
PHOSPHORYLASE)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.09A 1gfzA-1omoA:
undetectable		 1gfzA-1omoA:
18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1H8S_A_AICA1000_1
(MUTANT AL2 6E7P9G)		 5gru DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		6 / 12 TYR H 170
GLN H 223
PHE H 232
ASN L  36
ALA L  97
TRP L 106
 TYR  H 170 ( 1.3A)
GLN  H 223 ( 0.6A)
PHE  H 232 ( 1.3A)
ASN  L  36 ( 0.6A)
ALA  L  97 ( 0.0A)
TRP  L 106 ( 0.5A)
 0.74A 1h8sA-5gruH:
21.4		 1h8sA-5gruH:
29.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HVY_C_D16C416_1
(THYMIDYLATE SYNTHASE)		 3ab7 PUTATIVE
UNCHARACTERIZED
PROTEIN TTHA0350
(Thermus
thermophilus) 		5 / 11 ILE A 257
ASN A 259
ASP A 124
GLY A 125
PHE A 126
 ILE  A 257 ( 0.6A)
ASN  A 259 ( 0.6A)
ASP  A 124 ( 0.6A)
GLY  A 125 ( 0.0A)
PHE  A 126 ( 1.3A)
 1.34A 1hvyC-3ab7A:
undetectable		 1hvyC-3ab7A:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HWI_C_115C4_1
(HMG-COA REDUCTASE)		 1vho ENDOGLUCANASE
(Thermotoga
maritima) 		4 / 7 VAL A 177
SER A 174
ASN A 171
ASP A 225
 VAL  A 177 ( 0.6A)
SER  A 174 ( 0.0A)
ASN  A 171 ( 0.6A)
ASP  A 225 ( 0.6A)
 1.29A 1hwiC-1vhoA:
undetectable		 1hwiC-1vhoA:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HWI_D_115D3_2
(HMG-COA REDUCTASE)		 1vho ENDOGLUCANASE
(Thermotoga
maritima) 		4 / 7 VAL A 177
SER A 174
ASN A 171
ASP A 225
 VAL  A 177 ( 0.6A)
SER  A 174 ( 0.0A)
ASN  A 171 ( 0.6A)
ASP  A 225 ( 0.6A)
 1.29A 1hwiD-1vhoA:
undetectable		 1hwiD-1vhoA:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KIA_D_SAMD3293_0
(GLYCINE
N-METHYLTRANSFERASE)		 3h0l GLUTAMYL-TRNA(GLN)
AMIDOTRANSFERASE
SUBUNIT A
(Aquifex
aeolicus) 		5 / 12 GLY A 170
VAL A 422
SER A 166
SER A 124
TYR A 303
 ASN  A 901 (-3.6A)
None
None
ASN  A 901 (-3.0A)
None
 1.21A 1kiaD-3h0lA:
undetectable		 1kiaD-3h0lA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KIJ_A_NOVA400_2
(DNA GYRASE SUBUNIT B)		 2pnn TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 1
(Rattus
norvegicus) 		3 / 3 ASN A 301
PHE A 245
VAL A 294
 ASN  A 301 ( 0.6A)
PHE  A 245 ( 1.3A)
VAL  A 294 ( 0.5A)
 0.81A 1kijA-2pnnA:
undetectable		 1kijA-2pnnA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.06A 1l5qA-1omoA:
0.3		 1l5qA-1omoA:
17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L5Q_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.07A 1l5qB-1omoA:
undetectable		 1l5qB-1omoA:
17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_A_CFFA863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.02A 1l7xA-1omoA:
undetectable		 1l7xA-1omoA:
17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L7X_B_CFFB1863_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.01A 1l7xB-1omoA:
undetectable		 1l7xB-1omoA:
17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LHV_A_NOGA301_1
(SEX HORMONE-BINDING
GLOBULIN)		 1aoa T-FIMBRIN
(Homo
sapiens) 		4 / 8 THR A 354
ASP A 357
PHE A 352
ASN A 362
 THR  A 354 ( 0.8A)
ASP  A 357 ( 0.6A)
PHE  A 352 ( 1.3A)
ASN  A 362 ( 0.6A)
 0.97A 1lhvA-1aoaA:
undetectable		 1lhvA-1aoaA:
23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIK_A_ADNA699_1
(ADENOSINE KINASE)		 4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima) 		5 / 12 ASP A 143
LEU A  96
GLY A 142
ASN A 134
THR A  94
 ASP  A 143 ( 0.6A)
LEU  A  96 ( 0.6A)
GLY  A 142 ( 0.0A)
ASN  A 134 ( 0.6A)
THR  A  94 ( 0.8A)
 1.15A 1likA-4ursA:
undetectable		 1likA-4ursA:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MXD_A_ACRA733_1
(ALPHA AMYLASE)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		4 / 6 SER A 181
ASN A 186
LEU A 190
ASP A 187
 SER  A 181 ( 0.0A)
ASN  A 186 ( 0.6A)
LEU  A 190 ( 0.6A)
ASP  A 187 ( 0.6A)
 1.16A 1mxdA-4mwtA:
undetectable		 1mxdA-4mwtA:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MXG_A_ACRA443_1
(ALPHA AMYLASE)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		4 / 8 SER A 181
ASN A 186
LEU A 190
ASP A 187
 SER  A 181 ( 0.0A)
ASN  A 186 ( 0.6A)
LEU  A 190 ( 0.6A)
ASP  A 187 ( 0.6A)
 1.12A 1mxgA-4mwtA:
undetectable		 1mxgA-4mwtA:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N6C_A_SAMA402_0
(SET
DOMAIN-CONTAINING
PROTEIN 7)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 11 ILE A 127
ALA A 346
GLY A 394
GLU A 120
ASN A 398
 ILE  A 127 ( 0.7A)
ALA  A 346 ( 0.0A)
GLY  A 394 ( 0.0A)
GLU  A 120 ( 0.5A)
ASN  A 398 ( 0.6A)
 1.15A 1n6cA-5nqfA:
undetectable		 1n6cA-5nqfA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NBH_A_SAMA293_0
(GLYCINE
N-METHYLTRANSFERASE)		 3h0l GLUTAMYL-TRNA(GLN)
AMIDOTRANSFERASE
SUBUNIT A
(Aquifex
aeolicus) 		5 / 12 GLY A 170
VAL A 422
SER A 166
SER A 124
TYR A 303
 ASN  A 901 (-3.6A)
None
None
ASN  A 901 (-3.0A)
None
 1.20A 1nbhA-3h0lA:
undetectable		 1nbhA-3h0lA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NBH_C_SAMC2293_0
(GLYCINE
N-METHYLTRANSFERASE)		 3h0l GLUTAMYL-TRNA(GLN)
AMIDOTRANSFERASE
SUBUNIT A
(Aquifex
aeolicus) 		5 / 12 GLY A 170
VAL A 422
SER A 166
SER A 124
TYR A 303
 ASN  A 901 (-3.6A)
None
None
ASN  A 901 (-3.0A)
None
 1.21A 1nbhC-3h0lA:
undetectable		 1nbhC-3h0lA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NBH_D_SAMD3293_0
(GLYCINE
N-METHYLTRANSFERASE)		 3h0l GLUTAMYL-TRNA(GLN)
AMIDOTRANSFERASE
SUBUNIT A
(Aquifex
aeolicus) 		5 / 12 GLY A 170
VAL A 422
SER A 166
SER A 124
TYR A 303
 ASN  A 901 (-3.6A)
None
None
ASN  A 901 (-3.0A)
None
 1.21A 1nbhD-3h0lA:
undetectable		 1nbhD-3h0lA:
21.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1NCW_H_BEZH601_0
(IMMUNOGLOBULIN IGG2A)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 9 ASN L  36
TRP L  48
TYR L  51
GLY L 102
GLY H 225
 ASN  L  36 ( 0.6A)
TRP  L  48 ( 0.5A)
TYR  L  51 ( 1.3A)
GLY  L 102 ( 0.0A)
GLY  H 225 ( 0.0A)
 1.07A 1ncwH-5gruL:
23.2
1ncwL-5gruL:
15.0		 1ncwH-5gruL:
52.94
1ncwL-5gruL:
25.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ONI_I_BEZI518_0
(14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		4 / 7 ILE A 541
GLY A 539
ASN A 176
ASN A 142
 ILE  A 541 ( 0.7A)
GLY  A 539 ( 0.0A)
ASN  A 176 ( 0.6A)
ASN  A 142 ( 0.6A)
 1.01A 1oniG-5gprA:
undetectable
1oniI-5gprA:
0.8		 1oniG-5gprA:
14.23
1oniI-5gprA:
14.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PJ7_A_FFOA2887_0
(N,N-DIMETHYLGLYCINE
OXIDASE)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		5 / 12 LEU A  66
TYR A  84
GLY A  71
ASN A  90
LEU A  82
 LEU  A  66 ( 0.5A)
TYR  A  84 ( 1.3A)
GLY  A  71 ( 0.0A)
ASN  A  90 ( 0.6A)
LEU  A  82 ( 0.6A)
 1.20A 1pj7A-4mwtA:
1.4		 1pj7A-4mwtA:
19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Q8J_B_C2FB802_0
(5-METHYLTETRAHYDROFO
LATE S-HOMOCYSTEINE
METHYLTRANSFERASE)		 5d7w SERRALYSIN
(Serratia
marcescens) 		5 / 12 GLU A 329
ASN A 347
GLY A 363
SER A 311
ILE A 328
 GLU  A 329 (-0.6A)
ASN  A 347 (-0.6A)
GLY  A 363 (-0.0A)
SER  A 311 ( 0.0A)
ILE  A 328 ( 0.7A)
 1.12A 1q8jB-5d7wA:
undetectable		 1q8jB-5d7wA:
21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QZZ_A_ACTA421_0
(ACLACINOMYCIN-10-HYD
ROXYLASE)		 3h0l GLUTAMYL-TRNA(GLN)
AMIDOTRANSFERASE
SUBUNIT A
(Aquifex
aeolicus) 		4 / 8 ASP A 118
GLY A 123
GLY A 146
GLY A 145
 None
ASN  A 901 (-3.2A)
None
None
 0.62A 1qzzA-3h0lA:
undetectable		 1qzzA-3h0lA:
22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1R15_D_NCAD349_0
(ADP-RIBOSYL CYCLASE)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		3 / 3 GLU A 427
ASN A 445
TRP A 430
 GLU  A 427 ( 0.6A)
ASN  A 445 ( 0.6A)
TRP  A 430 ( 0.5A)
 1.19A 1r15D-5c05A:
undetectable		 1r15D-5c05A:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1R15_F_NCAF369_0
(ADP-RIBOSYL CYCLASE)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		3 / 3 GLU A 427
ASN A 445
TRP A 430
 GLU  A 427 ( 0.6A)
ASN  A 445 ( 0.6A)
TRP  A 430 ( 0.5A)
 1.16A 1r15F-5c05A:
undetectable		 1r15F-5c05A:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_A_SAMA801_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		4 / 6 TYR A 390
ASP A 454
ASN A 456
GLU A 412
 TYR  A 390 ( 1.3A)
ASP  A 454 ( 0.6A)
ASN  A 456 ( 0.6A)
GLU  A 412 ( 0.6A)
 1.03A 1rjdA-2ogsA:
2.7		 1rjdA-2ogsA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_A_SAMA801_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 6 ASP A 331
TYR A 272
ASN A 279
GLU A 319
 ASP  A 331 ( 0.6A)
TYR  A 272 (-1.3A)
ASN  A 279 ( 0.6A)
GLU  A 319 ( 0.5A)
 1.28A 1rjdA-3o96A:
undetectable		 1rjdA-3o96A:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_B_SAMB802_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		4 / 6 TYR A 390
ASP A 454
ASN A 456
GLU A 412
 TYR  A 390 ( 1.3A)
ASP  A 454 ( 0.6A)
ASN  A 456 ( 0.6A)
GLU  A 412 ( 0.6A)
 1.02A 1rjdB-2ogsA:
2.4		 1rjdB-2ogsA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_B_SAMB802_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 6 ASP A 331
TYR A 272
ASN A 279
GLU A 319
 ASP  A 331 ( 0.6A)
TYR  A 272 (-1.3A)
ASN  A 279 ( 0.6A)
GLU  A 319 ( 0.5A)
 1.28A 1rjdB-3o96A:
undetectable		 1rjdB-3o96A:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_C_SAMC803_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		4 / 6 TYR A 390
ASP A 454
ASN A 456
GLU A 412
 TYR  A 390 ( 1.3A)
ASP  A 454 ( 0.6A)
ASN  A 456 ( 0.6A)
GLU  A 412 ( 0.6A)
 1.05A 1rjdC-2ogsA:
3.0		 1rjdC-2ogsA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_C_SAMC803_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 6 ASP A 331
TYR A 272
ASN A 279
GLU A 319
 ASP  A 331 ( 0.6A)
TYR  A 272 (-1.3A)
ASN  A 279 ( 0.6A)
GLU  A 319 ( 0.5A)
 1.28A 1rjdC-3o96A:
undetectable		 1rjdC-3o96A:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RKW_A_PNTA225_0
(TRANSCRIPTIONAL
REGULATOR QACR)		 6gef TYPE IV SECRETION
SYSTEM PROTEIN DOTB
(Yersinia
pseudotuberculos
is) 		5 / 12 GLU A  24
LYS A  28
TYR A  17
GLU A  22
ASN A  67
 GLU  A  24 ( 0.6A)
LYS  A  28 ( 0.0A)
TYR  A  17 ( 1.3A)
GLU  A  22 ( 0.5A)
ASN  A  67 ( 0.6A)
 1.31A 1rkwA-6gefA:
0.0		 1rkwA-6gefA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS6_A_MTLA870_0
(NITRIC-OXIDE
SYNTHASE, BRAIN)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		4 / 8 SER A 112
ARG A 116
ASN A 135
TRP A 320
 SER  A 112 ( 0.0A)
ARG  A 116 ( 0.6A)
ASN  A 135 ( 0.6A)
TRP  A 320 ( 0.5A)
 1.27A 1rs6A-3ulkA:
undetectable		 1rs6A-3ulkA:
21.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RUA_H_BEZH601_0
(IMMUNOGLOBULIN
IGG2A, HEAVY CHAIN
IMMUNOGLOBULIN
IGG2A, LIGHT CHAIN)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 10 ASN L  36
TRP L  48
TYR L  51
GLY L 102
GLY H 225
 ASN  L  36 ( 0.6A)
TRP  L  48 ( 0.5A)
TYR  L  51 ( 1.3A)
GLY  L 102 ( 0.0A)
GLY  H 225 ( 0.0A)
 1.09A 1ruaH-5gruL:
23.5
1ruaL-5gruL:
20.5		 1ruaH-5gruL:
52.94
1ruaL-5gruL:
25.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RUL_H_BEZH601_0
(IMMUNOGLOBULIN
IGG2A, HEAVY CHAIN
IMMUNOGLOBULIN
IGG2A, LIGHT CHAIN)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 9 ASN L  36
TRP L  48
TYR L  51
GLY L 102
GLY H 225
 ASN  L  36 ( 0.6A)
TRP  L  48 ( 0.5A)
TYR  L  51 ( 1.3A)
GLY  L 102 ( 0.0A)
GLY  H 225 ( 0.0A)
 1.11A 1rulH-5gruL:
23.1
1rulL-5gruL:
15.0		 1rulH-5gruL:
52.94
1rulL-5gruL:
25.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RUM_H_BEZH1601_0
(IMMUNOGLOBULIN
IGG2A, HEAVY CHAIN
IMMUNOGLOBULIN
IGG2A, LIGHT CHAIN)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 9 ASN L  36
TRP L  48
TYR L  51
GLY L 102
GLY H 225
 ASN  L  36 ( 0.6A)
TRP  L  48 ( 0.5A)
TYR  L  51 ( 1.3A)
GLY  L 102 ( 0.0A)
GLY  H 225 ( 0.0A)
 1.06A 1rumH-5gruL:
23.0
1rumL-5gruL:
15.0		 1rumH-5gruL:
52.94
1rumL-5gruL:
25.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RUP_H_BEZH601_0
(IMMUNOGLOBULIN
IGG2A, HEAVY CHAIN
IMMUNOGLOBULIN
IGG2A, LIGHT CHAIN)		 5gru DIABODY PROTEIN
DIABODY PROTEIN
(Homo
sapiens;
Mus
musculus) 		5 / 9 ASN L  36
TRP L  48
TYR L  51
GLY L 102
GLY H 225
 ASN  L  36 ( 0.6A)
TRP  L  48 ( 0.5A)
TYR  L  51 ( 1.3A)
GLY  L 102 ( 0.0A)
GLY  H 225 ( 0.0A)
 1.07A 1rupH-5gruL:
23.1
1rupL-5gruL:
15.1		 1rupH-5gruL:
52.94
1rupL-5gruL:
25.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1U72_A_MTXA188_1
(DIHYDROFOLATE
REDUCTASE)		 4w65 GLYCOSYL HYDROLASE
FAMILY PROTEIN
(Mycolicibacteriu
m
fortuitum) 		5 / 12 ALA A 139
LEU A 250
PHE A  57
SER A 127
ASN A  66
 ALA  A 139 ( 0.0A)
LEU  A 250 ( 0.6A)
PHE  A  57 ( 1.3A)
SER  A 127 ( 0.0A)
ASN  A  66 ( 0.6A)
 1.23A 1u72A-4w65A:
undetectable		 1u72A-4w65A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VQ1_A_SAMA301_1
(N5-GLUTAMINE
METHYLTRANSFERASE,
HEMK)		 4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes) 		3 / 3 GLY A 143
ASP A  93
ASN A 167
 GLY  A 143 ( 0.0A)
ASP  A  93 ( 0.6A)
ASN  A 167 ( 0.6A)
 0.62A 1vq1A-4g41A:
undetectable		 1vq1A-4g41A:
23.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WOP_A_FFOA2887_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		6 / 12 MET A  56
TYR A 113
VAL A 115
ASN A 117
TYR A 197
ARG A 233
 MET  A  56 (-0.0A)
TYR  A 113 ( 1.3A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
 1.15A 1wopA-1wsvA:
50.1		 1wopA-1wsvA:
34.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WOP_A_FFOA2887_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		7 / 12 MET A  56
VAL A 115
ASN A 117
TYR A 371
TYR A 197
ARG A 233
TRP A 262
 MET  A  56 (-0.0A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 371 (-1.3A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
TRP  A 262 ( 0.5A)
 1.09A 1wopA-1wsvA:
50.1		 1wopA-1wsvA:
34.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WOP_A_FFOA2887_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		5 / 12 VAL A 115
TYR A 113
ASN A 117
TYR A 197
ARG A 233
 VAL  A 115 (-0.6A)
TYR  A 113 ( 1.3A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
 1.48A 1wopA-1wsvA:
50.1		 1wopA-1wsvA:
34.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WSV_A_THHA3001_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		12 / 12 MET A  56
THR A  87
LEU A  88
ILE A 103
VAL A 115
ASN A 117
PHE A 176
MET A 177
TYR A 197
ARG A 233
LEU A 242
TRP A 262
 MET  A  56 (-0.0A)
THR  A  87 ( 0.8A)
LEU  A  88 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
PHE  A 176 (-1.3A)
MET  A 177 (-0.0A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
LEU  A 242 (-0.6A)
TRP  A 262 ( 0.5A)
 0.02A 1wsvA-1wsvA:
66.6		 1wsvA-1wsvA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WSV_A_THHA3001_0
(AMINOMETHYLTRANSFERA
SE)		 4ikn AP-3 COMPLEX SUBUNIT
MU-1
(Rattus
norvegicus) 		5 / 12 THR A 294
LEU A 351
ILE A 295
VAL A 274
ASN A 300
 THR  A 294 ( 0.8A)
LEU  A 351 ( 0.6A)
ILE  A 295 ( 0.6A)
VAL  A 274 ( 0.5A)
ASN  A 300 ( 0.6A)
 1.18A 1wsvA-4iknA:
undetectable		 1wsvA-4iknA:
22.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WSV_B_THHB4001_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		11 / 12 MET A  56
THR A  87
LEU A  88
ILE A 103
VAL A 115
ASN A 117
PHE A 176
MET A 177
TYR A 197
LEU A 242
TRP A 262
 MET  A  56 (-0.0A)
THR  A  87 ( 0.8A)
LEU  A  88 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
PHE  A 176 (-1.3A)
MET  A 177 (-0.0A)
TYR  A 197 (-1.3A)
LEU  A 242 (-0.6A)
TRP  A 262 ( 0.5A)
 0.19A 1wsvB-1wsvA:
62.3		 1wsvB-1wsvA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WSV_B_THHB4001_0
(AMINOMETHYLTRANSFERA
SE)		 4ikn AP-3 COMPLEX SUBUNIT
MU-1
(Rattus
norvegicus) 		5 / 12 THR A 294
LEU A 351
ILE A 295
VAL A 274
ASN A 300
 THR  A 294 ( 0.8A)
LEU  A 351 ( 0.6A)
ILE  A 295 ( 0.6A)
VAL  A 274 ( 0.5A)
ASN  A 300 ( 0.6A)
 1.23A 1wsvB-4iknA:
undetectable		 1wsvB-4iknA:
22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1X70_A_715A801_1
(DIPEPTIDYL PEPTIDASE
IV)		 1szb MANNOSE BINDING
LECTIN-ASSOCIATED
SERINE PROTEASE-2
RELATED PROTEIN,
MAP19 (19KDA)
(Homo
sapiens) 		5 / 12 GLU A  52
SER A  54
PHE A  61
TYR A  24
ASN A 108
 GLU  A  52 (-0.6A)
SER  A  54 ( 0.0A)
PHE  A  61 ( 1.3A)
TYR  A  24 ( 1.3A)
ASN  A 108 (-0.6A)
 1.05A 1x70A-1szbA:
undetectable		 1x70A-1szbA:
11.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XKK_A_FMMA91_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)		 6h20 -
(-) 		6 / 12 ALA A 144
THR A 211
GLY A 101
LEU A 104
THR A 249
ASP A 250
 ASN  A 401 ( 4.3A)
ASN  A 401 (-4.0A)
None
None
ASN  A 401 ( 4.9A)
ASN  A 401 (-2.9A)
 1.27A 1xkkA-6h20A:
undetectable		 1xkkA-6h20A:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XLX_A_CIOA101_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
HIS A 204
MET A 273
LEU A 319
ASN A 321
THR A 333
ILE A 336
MET A 337
SER A 368
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
HIS  A 204 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.54A 1xlxA-3sl5A:
51.0		 1xlxA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XMU_A_ROFA101_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 5 MET A 273
ASN A 321
THR A 333
MET A 337
GLN A 369
 MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
THR  A 333 ( 0.8A)
MET  A 337 ( 0.0A)
GLN  A 369 (-0.6A)
 0.26A 1xmuA-3sl5A:
51.4		 1xmuA-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XMU_B_ROFB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		5 / 5 ASN A 321
THR A 333
MET A 337
GLN A 369
PHE A 372
 ASN  A 321 (-0.6A)
THR  A 333 ( 0.8A)
MET  A 337 ( 0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.51A 1xmuB-3sl5A:
51.1		 1xmuB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOQ_A_ROFA502_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		3 / 3 ASN A 321
TRP A 332
GLN A 369
 ASN  A 321 (-0.6A)
TRP  A 332 ( 0.5A)
GLN  A 369 (-0.6A)
 0.25A 1xoqA-3sl5A:
53.5		 1xoqA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOQ_B_ROFB501_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		3 / 3 MET A 273
ASN A 321
GLN A 369
 MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
GLN  A 369 (-0.6A)
 0.31A 1xoqB-3sl5A:
53.4		 1xoqB-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOT_B_VDNB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
LEU A 319
ASN A 321
ILE A 336
MET A 337
SER A 355
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 355 ( 0.0A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.59A 1xotB-3sl5A:
50.9		 1xotB-3sl5A:
84.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XOT_B_VDNB102_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
LEU A 319
ASN A 321
ILE A 336
MET A 337
SER A 355
MET A 357
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
SER  A 355 ( 0.0A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.73A 1xotB-3sl5A:
50.9		 1xotB-3sl5A:
84.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z95_A_198A501_2
(ANDROGEN RECEPTOR)		 2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1
(Homo
sapiens) 		4 / 6 ASN A 302
LEU A 118
LEU A 296
ILE A  14
 ASN  A 302 ( 0.6A)
LEU  A 118 ( 0.5A)
LEU  A 296 ( 0.5A)
ILE  A  14 ( 0.6A)
 0.96A 1z95A-2b92A:
undetectable		 1z95A-2b92A:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZLQ_A_ACTA1502_0
(NICKEL-BINDING
PERIPLASMIC PROTEIN)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		4 / 5 PRO A 329
GLY A 105
ASN A 335
GLY A 103
 PRO  A 329 ( 1.1A)
GLY  A 105 ( 0.0A)
ASN  A 335 ( 0.6A)
GLY  A 103 ( 0.0A)
 1.16A 1zlqA-4mwtA:
undetectable		 1zlqA-4mwtA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZQ9_A_SAMA4000_1
(PROBABLE
DIMETHYLADENOSINE
TRANSFERASE)		 5w0a GLUCANASE
(Trichoderma
harzianum) 		3 / 3 GLY A 140
GLU A 141
ASN A 326
 GLY  A 140 ( 0.0A)
GLU  A 141 ( 0.6A)
ASN  A 326 ( 0.6A)
 0.72A 1zq9A-5w0aA:
undetectable		 1zq9A-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A8T_B_ADNB252_1
(U8 SNORNA-BINDING
PROTEIN X29)		 4dlk PHOSPHORIBOSYLAMINOI
MIDAZOLE
CARBOXYLASE, ATPASE
SUBUNIT
(Bacillus
anthracis) 		4 / 8 GLY A  17
ASN A  42
SER A  43
GLN A  47
 GLY  A  17 ( 0.0A)
ASN  A  42 ( 0.6A)
SER  A  43 ( 0.0A)
GLN  A  47 (-0.6A)
 0.93A 2a8tB-4dlkA:
undetectable		 2a8tB-4dlkA:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BJF_A_DXCA330_0
(CHOLOYLGLYCINE
HYDROLASE)		 2qc5 STREPTOGRAMIN B
LACTONASE
(Staphylococcus
cohnii) 		5 / 12 PHE A 145
ASN A  75
ILE A  63
ILE A 112
THR A  73
 PHE  A 145 ( 1.3A)
ASN  A  75 ( 0.6A)
ILE  A  63 ( 0.4A)
ILE  A 112 ( 0.7A)
THR  A  73 ( 0.8A)
 1.30A 2bjfA-2qc5A:
undetectable		 2bjfA-2qc5A:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BJF_A_DXCA330_0
(CHOLOYLGLYCINE
HYDROLASE)		 4ikn AP-3 COMPLEX SUBUNIT
MU-1
(Rattus
norvegicus) 		5 / 12 MET A 314
PHE A 282
ASN A 372
THR A 418
LEU A 373
 MET  A 314 ( 0.0A)
PHE  A 282 ( 1.3A)
ASN  A 372 ( 0.6A)
THR  A 418 ( 0.8A)
LEU  A 373 ( 0.5A)
 1.19A 2bjfA-4iknA:
undetectable		 2bjfA-4iknA:
21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BM9_A_SAMA301_1
(CEPHALOSPORIN
HYDROXYLASE CMCI)		 2an1 PUTATIVE KINASE
(Salmonella
enterica) 		3 / 3 LYS A 284
ASP A 105
ASN A  97
 LYS  A 284 ( 0.0A)
ASP  A 105 ( 0.6A)
ASN  A  97 ( 0.6A)
 1.16A 2bm9A-2an1A:
2.8		 2bm9A-2an1A:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BM9_D_SAMD301_1
(CEPHALOSPORIN
HYDROXYLASE CMCI)		 1ted PKS18
(Mycobacterium
tuberculosis) 		3 / 3 ASP A 389
ASP A 308
ASN A 300
 ASP  A 389 ( 0.6A)
ASP  A 308 ( 0.5A)
ASN  A 300 ( 0.6A)
 0.74A 2bm9D-1tedA:
undetectable		 2bm9D-1tedA:
23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BR4_B_SAMB301_0
(CEPHALOSPORIN
HYDROXYLASE CMCI)		 3i4k MUCONATE LACTONIZING
ENZYME
(Corynebacterium
glutamicum) 		5 / 12 GLY A  49
ASN A  45
ASP A 116
ALA A 113
ALA A 109
 GLY  A  49 ( 0.0A)
ASN  A  45 ( 0.6A)
ASP  A 116 ( 0.6A)
ALA  A 113 ( 0.0A)
ALA  A 109 ( 0.0A)
 1.28A 2br4B-3i4kA:
undetectable		 2br4B-3i4kA:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DTJ_A_THRA401_0
(ASPARTOKINASE)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		4 / 8 ASP A 344
GLY A 420
THR A 347
ASN A 416
 ASP  A 344 ( 0.6A)
GLY  A 420 ( 0.0A)
THR  A 347 ( 0.8A)
ASN  A 416 ( 0.6A)
 0.77A 2dtjA-4kqnA:
undetectable
2dtjB-4kqnA:
undetectable		 2dtjA-4kqnA:
15.84
2dtjB-4kqnA:
15.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EJT_A_SAMA501_1
(N(2),N(2)-DIMETHYLGU
ANOSINE TRNA
METHYLTRANSFERASE)		 6h20 -
(-) 		3 / 3 ARG A 325
ASP A 181
ASP A 250
 None
None
ASN  A 401 (-2.9A)
 0.85A 2ejtA-6h20A:
undetectable		 2ejtA-6h20A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_A_MIXA539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		7 / 12 LEU A 156
VAL A 164
ALA A 177
ASP A 274
LYS A 276
ASN A 279
MET A 281
 LEU  A 156 ( 0.6A)
VAL  A 164 ( 0.6A)
ALA  A 177 ( 0.0A)
ASP  A 274 ( 0.5A)
LYS  A 276 ( 0.0A)
ASN  A 279 ( 0.6A)
MET  A 281 ( 0.0A)
 0.83A 2fumA-3o96A:
24.2		 2fumA-3o96A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_D_MIXD3539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		7 / 12 LEU A 156
VAL A 164
ALA A 177
MET A 227
LYS A 276
ASN A 279
MET A 281
 LEU  A 156 ( 0.6A)
VAL  A 164 ( 0.6A)
ALA  A 177 ( 0.0A)
MET  A 227 ( 0.0A)
LYS  A 276 ( 0.0A)
ASN  A 279 ( 0.6A)
MET  A 281 ( 0.0A)
 0.92A 2fumD-3o96A:
24.0		 2fumD-3o96A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G72_A_SAMA2001_1
(PHENYLETHANOLAMINE
N-METHYLTRANSFERASE)		 3h0l GLUTAMYL-TRNA(GLN)
AMIDOTRANSFERASE
SUBUNIT A
(Aquifex
aeolicus) 		4 / 6 TYR A 303
GLY A 123
TYR A 302
ASP A 118
 None
ASN  A 901 (-3.2A)
ASN  A 901 (-4.6A)
None
 1.27A 2g72A-3h0lA:
undetectable		 2g72A-3h0lA:
18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G72_A_SAMA2001_1
(PHENYLETHANOLAMINE
N-METHYLTRANSFERASE)		 3qvi HISTO-ASPARTIC
PROTEASE
(Plasmodium
falciparum) 		4 / 6 TYR A  56
GLY A  21
ASP A  22
ASN A  23
 TYR  A  56 ( 1.3A)
GLY  A  21 ( 0.0A)
ASP  A  22 ( 0.5A)
ASN  A  23 ( 0.6A)
 1.15A 2g72A-3qviA:
undetectable		 2g72A-3qviA:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2H42_B_VIAB902_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE)		 4yzr POLYKETIDE
BIOSYNTHESIS
CYTOCHROME P450 PKSS
(Bacillus
subtilis) 		5 / 12 HIS A 342
ASN A 340
ALA A 358
ALA A 277
ILE A 274
 HIS  A 342 ( 1.0A)
ASN  A 340 ( 0.6A)
ALA  A 358 (-0.0A)
ALA  A 277 ( 0.0A)
ILE  A 274 ( 0.4A)
 1.08A 2h42B-4yzrA:
undetectable		 2h42B-4yzrA:
22.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HKK_A_ALEA300_1
(CARBONIC ANHYDRASE 2)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 6 ASN A 368
ILE A 375
GLN A 371
THR A  37
 ASN  A 368 ( 0.6A)
ILE  A 375 ( 0.7A)
GLN  A 371 ( 0.6A)
THR  A  37 ( 0.8A)
 1.26A 2hkkA-3r6yA:
undetectable		 2hkkA-3r6yA:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HKK_A_ALEA300_1
(CARBONIC ANHYDRASE 2)		 4ikn AP-3 COMPLEX SUBUNIT
MU-1
(Rattus
norvegicus) 		4 / 6 HIS A 313
ASN A 374
ILE A 190
GLN A 415
 HIS  A 313 ( 1.0A)
ASN  A 374 ( 0.6A)
ILE  A 190 ( 0.7A)
GLN  A 415 ( 0.6A)
 1.16A 2hkkA-4iknA:
undetectable		 2hkkA-4iknA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IJ7_A_TPFA2472_1
(CYTOCHROME P450 121)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		5 / 11 THR A 135
ASN A  18
MET A  17
THR A 123
ALA A 126
 THR  A 135 ( 0.8A)
ASN  A  18 ( 0.6A)
MET  A  17 ( 0.0A)
THR  A 123 ( 0.8A)
ALA  A 126 ( 0.0A)
 1.27A 2ij7A-2ogsA:
0.0		 2ij7A-2ogsA:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IJ7_B_TPFB2470_1
(CYTOCHROME P450 121)		 2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50
(Geobacillus
stearothermophil
us) 		5 / 9 THR A 135
ASN A  18
MET A  17
THR A 123
ALA A 126
 THR  A 135 ( 0.8A)
ASN  A  18 ( 0.6A)
MET  A  17 ( 0.0A)
THR  A 123 ( 0.8A)
ALA  A 126 ( 0.0A)
 1.29A 2ij7B-2ogsA:
0.0		 2ij7B-2ogsA:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IJ7_D_TPFD2473_1
(CYTOCHROME P450 121)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 10 THR A 465
VAL A 464
ASN A 495
THR A 434
ALA A 436
 THR  A 465 ( 0.9A)
VAL  A 464 ( 0.6A)
ASN  A 495 ( 0.6A)
THR  A 434 ( 0.9A)
ALA  A 436 ( 0.0A)
 1.32A 2ij7D-1v0fA:
0.0		 2ij7D-1v0fA:
20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IYF_A_ERYA1400_0
(OLEANDOMYCIN
GLYCOSYLTRANSFERASE)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		5 / 11 HIS A 150
ASN A 359
PHE A 366
ASN A 226
ASP A 266
 HIS  A 150 ( 1.0A)
ASN  A 359 ( 0.6A)
PHE  A 366 ( 1.3A)
ASN  A 226 ( 0.6A)
ASP  A 266 ( 0.6A)
 1.22A 2iyfA-3r6yA:
undetectable		 2iyfA-3r6yA:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JN3_A_JN3A131_2
(FATTY ACID-BINDING
PROTEIN, LIVER)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 6 LEU A 313
ASN A 319
GLN A 270
PHE A 281
 LEU  A 313 ( 0.5A)
ASN  A 319 ( 0.6A)
GLN  A 270 ( 0.6A)
PHE  A 281 ( 1.3A)
 1.21A 2jn3A-3gnrA:
undetectable		 2jn3A-3gnrA:
13.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OKC_B_SAMB500_0
(TYPE I RESTRICTION
ENZYME STYSJI M
PROTEIN)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		5 / 12 ALA A 543
ASN A 541
VAL A 206
ASN A 480
ARG A 564
 ALA  A 543 ( 0.0A)
ASN  A 541 (-0.6A)
VAL  A 206 ( 0.6A)
ASN  A 480 ( 0.6A)
ARG  A 564 ( 0.6A)
 1.12A 2okcB-5c05A:
undetectable		 2okcB-5c05A:
22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PYM_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 1txu RAB5 GDP/GTP
EXCHANGE FACTOR
(Homo
sapiens) 		3 / 3 ASP A 260
ASN A 258
THR A 318
 ASP  A 260 ( 0.5A)
ASN  A 258 ( 0.6A)
THR  A 318 ( 0.8A)
 0.70A 2pymB-1txuA:
undetectable		 2pymB-1txuA:
18.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PYM_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 2v9u MSPA
(Mycolicibacteriu
m
smegmatis) 		3 / 3 ASP A   3
ASN A   4
THR A  17
 ASP  A   3 ( 0.6A)
ASN  A   4 ( 0.6A)
THR  A  17 ( 0.8A)
 0.60A 2pymB-2v9uA:
undetectable		 2pymB-2v9uA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q63_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii) 		3 / 3 ARG A 257
ASN A 328
THR A 264
 ARG  A 257 ( 0.6A)
ASN  A 328 ( 0.6A)
THR  A 264 ( 0.8A)
 0.85A 2q63A-1wqaA:
undetectable		 2q63A-1wqaA:
13.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q63_A_1UNA1001_4
(PROTEASE RETROPEPSIN)		 1txu RAB5 GDP/GTP
EXCHANGE FACTOR
(Homo
sapiens) 		3 / 3 ASP A 260
ASN A 258
THR A 318
 ASP  A 260 ( 0.5A)
ASN  A 258 ( 0.6A)
THR  A 318 ( 0.8A)
 0.70A 2q63B-1txuA:
undetectable		 2q63B-1txuA:
18.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q63_A_1UNA1001_4
(PROTEASE RETROPEPSIN)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		3 / 3 ASP A 473
ASN A 471
THR A 468
 ASP  A 473 ( 0.5A)
ASN  A 471 ( 0.6A)
THR  A 468 ( 0.8A)
 0.78A 2q63B-2nvvA:
undetectable		 2q63B-2nvvA:
12.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q63_A_1UNA1001_4
(PROTEASE RETROPEPSIN)		 2v9u MSPA
(Mycolicibacteriu
m
smegmatis) 		3 / 3 ASP A   3
ASN A   4
THR A  17
 ASP  A   3 ( 0.6A)
ASN  A   4 ( 0.6A)
THR  A  17 ( 0.8A)
 0.49A 2q63B-2v9uA:
undetectable		 2q63B-2v9uA:
24.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QEU_B_ACTB141_0
(PUTATIVE
CARBOXYMUCONOLACTONE
DECARBOXYLASE)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		3 / 3 PRO A 403
ASN A 401
ARG A 459
 PRO  A 403 (-1.1A)
ASN  A 401 ( 0.6A)
ARG  A 459 ( 0.6A)
 1.05A 2qeuB-3gnrA:
1.8		 2qeuB-3gnrA:
13.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QEU_B_ACTB141_0
(PUTATIVE
CARBOXYMUCONOLACTONE
DECARBOXYLASE)		 4cgu PROTEIN INTERACTING
WITH HSP90 1
(Saccharomyces
cerevisiae) 		3 / 3 PRO B 265
ASN B 287
ARG B 338
 PRO  B 265 ( 1.1A)
ASN  B 287 ( 0.6A)
ARG  B 338 ( 0.6A)
 1.01A 2qeuB-4cguB:
undetectable		 2qeuB-4cguB:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QHF_A_ACTA507_0
(CHORISMATE SYNTHASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		3 / 3 LEU A 216
ASN A 210
ARG A 199
 LEU  A 216 ( 0.6A)
ASN  A 210 ( 0.6A)
ARG  A 199 ( 0.6A)
 0.87A 2qhfA-5nqfA:
undetectable		 2qhfA-5nqfA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VN0_A_TDZA501_1
(CYTOCHROME P450 2C8)		 1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii) 		5 / 12 LEU A 445
ASN A 444
VAL A 401
VAL A 418
THR A 375
 LEU  A 445 ( 0.6A)
ASN  A 444 ( 0.6A)
VAL  A 401 ( 0.6A)
VAL  A 418 ( 0.6A)
THR  A 375 ( 0.8A)
 1.19A 2vn0A-1wqaA:
0.0		 2vn0A-1wqaA:
22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3M_A_FOLA1188_0
(DIHYDROFOLATE
REDUCTASE)		 5wpi HSVA
(Erwinia
amylovora) 		5 / 12 ILE A  38
ALA A 119
ILE A  51
PRO A  52
ASN A  55
 ILE  A  38 ( 0.7A)
ALA  A 119 ( 0.0A)
ILE  A  51 ( 0.7A)
PRO  A  52 ( 1.1A)
ASN  A  55 ( 0.6A)
 1.01A 2w3mA-5wpiA:
undetectable		 2w3mA-5wpiA:
18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W8Y_A_486A1000_2
(PROGESTERONE
RECEPTOR)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		4 / 7 LEU A 406
ASN A 410
LEU A 225
TYR A 426
 LEU  A 406 ( 0.6A)
ASN  A 410 ( 0.6A)
LEU  A 225 ( 0.6A)
TYR  A 426 ( 1.3A)
 1.23A 2w8yA-3ulkA:
undetectable		 2w8yA-3ulkA:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEK_B_DIFB1374_1
(ZINC-BINDING ALCOHOL
DEHYDROGENASE
DOMAIN-CONTAINING
PROTEIN 2)		 5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4
(Homo
sapiens) 		4 / 6 PRO A 220
ILE A 217
ASN A 347
LEU A 213
 PRO  A 220 ( 1.1A)
ILE  A 217 ( 0.7A)
ASN  A 347 ( 0.6A)
LEU  A 213 ( 0.5A)
 1.37A 2wekB-5nksA:
undetectable		 2wekB-5nksA:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X0P_A_ADNA1607_1
(ALCALIGIN
BIOSYNTHESIS PROTEIN)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		4 / 8 GLY A 227
ASN A 410
MET A 409
GLU A 221
 GLY  A 227 ( 0.0A)
ASN  A 410 ( 0.6A)
MET  A 409 ( 0.0A)
GLU  A 221 (-0.6A)
 0.80A 2x0pA-3ulkA:
0.5		 2x0pA-3ulkA:
22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X2I_B_QPSB1060_1
(ALPHA-1,4-GLUCAN
LYASE ISOZYME 1)		 5ve2 ENOYL-COA HYDRATASE
(Pseudoalteromona
s
atlantica) 		5 / 10 VAL A 184
SER A  15
SER A   8
ASN A  11
ALA A 191
 VAL  A 184 ( 0.6A)
SER  A  15 ( 0.0A)
SER  A   8 ( 0.0A)
ASN  A  11 ( 0.6A)
ALA  A 191 ( 0.0A)
 1.47A 2x2iB-5ve2A:
undetectable		 2x2iB-5ve2A:
12.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XN3_A_ID8A1356_1
(THYROXINE-BINDING
GLOBULIN)		 3sag EXOSOME COMPONENT 10
(Homo
sapiens) 		4 / 8 LEU A 356
LEU A 297
ASN A 301
LEU A 304
 LEU  A 356 ( 0.6A)
LEU  A 297 ( 0.6A)
ASN  A 301 ( 0.6A)
LEU  A 304 ( 0.6A)
 1.10A 2xn3A-3sagA:
undetectable
2xn3B-3sagA:
undetectable		 2xn3A-3sagA:
21.97
2xn3B-3sagA:
9.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y6R_A_CTCA1385_0
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 10 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.21A 2y6rA-5gprA:
undetectable		 2y6rA-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YOE_C_FL7C1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 5k66 NTA1P
(Saccharomyces
cerevisiae) 		4 / 8 GLY A 403
ASN A 390
THR A 399
TYR A 140
 None
None
None
ASN  A 501 ( 3.6A)
 0.86A 2yoeB-5k66A:
undetectable
2yoeC-5k66A:
undetectable		 2yoeB-5k66A:
20.56
2yoeC-5k66A:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZSE_A_PAUA600_0
(PANTOTHENATE KINASE)		 3sag EXOSOME COMPONENT 10
(Homo
sapiens) 		4 / 7 TYR A 382
PHE A 198
ILE A 202
ASN A 353
 TYR  A 382 ( 1.3A)
PHE  A 198 ( 1.3A)
ILE  A 202 ( 0.7A)
ASN  A 353 ( 0.6A)
 1.24A 2zseA-3sagA:
undetectable		 2zseA-3sagA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZVJ_A_SAMA301_0
(CATECHOL
O-METHYLTRANSFERASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 ASN A 293
VAL A 294
MET A 224
ASN A 225
HIS A 220
 ASN  A 293 ( 0.6A)
VAL  A 294 ( 0.6A)
MET  A 224 ( 0.0A)
ASN  A 225 ( 0.6A)
HIS  A 220 ( 1.0A)
 1.49A 2zvjA-5nqfA:
undetectable		 2zvjA-5nqfA:
19.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZWE_B_DAHB98_1
(TYROSINASE
MELC)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 0.96A 2zweA-3ulkA:
undetectable
2zweB-3ulkA:
undetectable		 2zweA-3ulkA:
19.11
2zweB-3ulkA:
13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZWF_B_DAHB98_1
(TYROSINASE
MELC)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 0.96A 2zwfA-3ulkA:
undetectable
2zwfB-3ulkA:
undetectable		 2zwfA-3ulkA:
19.11
2zwfB-3ulkA:
13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZWG_B_DAHB98_1
(TYROSINASE
MELC)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 0.97A 2zwgA-3ulkA:
undetectable
2zwgB-3ulkA:
undetectable		 2zwgA-3ulkA:
19.11
2zwgB-3ulkA:
13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZZM_A_SAMA401_1
(UNCHARACTERIZED
PROTEIN MJ0883)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		3 / 3 ARG A  79
ASP A  62
ASN A 412
 ARG  A  79 ( 0.6A)
ASP  A  62 ( 0.6A)
ASN  A 412 ( 0.6A)
 0.89A 2zzmA-4kqnA:
undetectable		 2zzmA-4kqnA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZZN_B_SAMB402_0
(UNCHARACTERIZED
PROTEIN MJ0883)		 3qvi HISTO-ASPARTIC
PROTEASE
(Plasmodium
falciparum) 		5 / 12 LEU A 140
PHE A  29
GLY A 122
ASN A  37
PHE A  27
 LEU  A 140 ( 0.6A)
PHE  A  29 ( 1.3A)
GLY  A 122 ( 0.0A)
ASN  A  37 ( 0.6A)
PHE  A  27 ( 1.3A)
 1.40A 2zznB-3qviA:
undetectable		 2zznB-3qviA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A51_A_VDYA6178_1
(VITAMIN D
HYDROXYLASE)		 4mtp RNA DEPENDENT RNA
POLYMERASE
(Japanese
encephalitis
virus) 		5 / 11 ILE A 571
ASN A 377
LEU A 556
VAL A 608
LEU A 612
 ILE  A 571 ( 0.7A)
ASN  A 377 ( 0.6A)
LEU  A 556 ( 0.6A)
VAL  A 608 ( 0.6A)
LEU  A 612 ( 0.6A)
 1.09A 3a51A-4mtpA:
undetectable		 3a51A-4mtpA:
19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A51_B_VDYB6178_1
(VITAMIN D
HYDROXYLASE)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		5 / 12 PRO A 330
LEU A 311
ASN A 293
VAL A 181
LEU A 197
 PRO  A 330 ( 1.1A)
LEU  A 311 ( 0.6A)
ASN  A 293 ( 0.6A)
VAL  A 181 ( 0.6A)
LEU  A 197 ( 0.5A)
 1.11A 3a51B-3r6yA:
undetectable		 3a51B-3r6yA:
23.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A65_A_ACAA601_1
(6-AMINOHEXANOATE-DIM
ER HYDROLASE)		 2an1 PUTATIVE KINASE
(Salmonella
enterica) 		5 / 12 ALA A  67
VAL A 116
ASN A  89
GLY A   9
ILE A   8
 ALA  A  67 ( 0.0A)
VAL  A 116 ( 0.6A)
ASN  A  89 ( 0.6A)
GLY  A   9 ( 0.0A)
ILE  A   8 ( 0.7A)
 1.47A 3a65A-2an1A:
undetectable		 3a65A-2an1A:
21.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_A_C2FA401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		7 / 12 MET A  56
ASP A 101
ILE A 103
VAL A 115
ASN A 117
TYR A 197
ARG A 233
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
 0.28A 3a8iA-1wsvA:
46.8		 3a8iA-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_A_C2FA401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		6 / 12 MET A  56
ASP A 101
TYR A 113
VAL A 115
ASN A 117
ARG A 233
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
TYR  A 113 ( 1.3A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
ARG  A 233 (-0.6A)
 1.11A 3a8iA-1wsvA:
46.8		 3a8iA-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_B_C2FB401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		8 / 12 MET A  56
ASP A 101
ILE A 103
VAL A 115
ASN A 117
TYR A 197
ARG A 233
TRP A 262
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
TRP  A 262 ( 0.5A)
 0.32A 3a8iB-1wsvA:
46.2		 3a8iB-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_B_C2FB401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		6 / 12 MET A  56
ASP A 101
TYR A 113
VAL A 115
ASN A 117
ARG A 233
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
TYR  A 113 ( 1.3A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
ARG  A 233 (-0.6A)
 1.12A 3a8iB-1wsvA:
46.2		 3a8iB-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_C_C2FC401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		7 / 12 MET A  56
ILE A 103
VAL A 115
ASN A 117
TYR A 197
ARG A 233
TRP A 262
 MET  A  56 (-0.0A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
TRP  A 262 ( 0.5A)
 0.44A 3a8iC-1wsvA:
46.4		 3a8iC-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_C_C2FC401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		6 / 12 MET A  56
TYR A 113
VAL A 115
ASN A 117
TYR A 197
ARG A 233
 MET  A  56 (-0.0A)
TYR  A 113 ( 1.3A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
 1.16A 3a8iC-1wsvA:
46.4		 3a8iC-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_D_C2FD401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		8 / 12 MET A  56
ASP A 101
ILE A 103
VAL A 115
ASN A 117
TYR A 197
ARG A 233
TRP A 262
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
ILE  A 103 (-0.7A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
TRP  A 262 ( 0.5A)
 0.39A 3a8iD-1wsvA:
46.3		 3a8iD-1wsvA:
33.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3A8I_D_C2FD401_0
(AMINOMETHYLTRANSFERA
SE)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		7 / 12 MET A  56
ASP A 101
TYR A 113
VAL A 115
ASN A 117
TYR A 197
ARG A 233
 MET  A  56 (-0.0A)
ASP  A 101 (-0.6A)
TYR  A 113 ( 1.3A)
VAL  A 115 (-0.6A)
ASN  A 117 (-0.6A)
TYR  A 197 (-1.3A)
ARG  A 233 (-0.6A)
 1.12A 3a8iD-1wsvA:
46.3		 3a8iD-1wsvA:
33.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AVO_A_PAUA314_0
(PANTOTHENATE KINASE)		 5w6l RTX
REPEAT-CONTAINING
CYTOTOXIN
(Vibrio
vulnificus) 		5 / 11 VAL A3665
LEU A3598
HIS A3624
ILE A3642
ASN A3639
 VAL  A3665 ( 0.6A)
LEU  A3598 ( 0.6A)
HIS  A3624 ( 1.0A)
ILE  A3642 ( 0.7A)
ASN  A3639 ( 0.6A)
 1.31A 3avoA-5w6lA:
undetectable		 3avoA-5w6lA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BCR_A_AZZA940_1
(GLYCOGEN
PHOSPHORYLASE,
MUSCLE FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 5 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.11A 3bcrA-1omoA:
undetectable		 3bcrA-1omoA:
18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BJW_F_SVRF509_2
(PHOSPHOLIPASE A2)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		4 / 8 TYR A 131
ASN A 177
PHE A 460
TRP A 444
 TYR  A 131 ( 1.3A)
ASN  A 177 (-0.6A)
PHE  A 460 (-1.3A)
TRP  A 444 (-0.5A)
 1.42A 3bjwD-3gnrA:
undetectable		 3bjwD-3gnrA:
12.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CB8_A_SAMA501_0
(PYRUVATE
FORMATE-LYASE
1-ACTIVATING ENZYME)		 1ng0 COAT PROTEIN
(Cocksfoot
mottle
virus) 		5 / 12 TYR A 213
ASN A 206
GLU A 203
ARG A 217
VAL A 214
 TYR  A 213 ( 1.3A)
ASN  A 206 ( 0.6A)
GLU  A 203 ( 0.5A)
ARG  A 217 ( 0.6A)
VAL  A 214 ( 0.6A)
 1.13A 3cb8A-1ng0A:
undetectable		 3cb8A-1ng0A:
20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CCF_A_BEZA261_0
(CYCLOPROPANE-FATTY-A
CYL-PHOSPHOLIPID
SYNTHASE)		 1ryn PROTEIN CRS2
(Zea
mays) 		4 / 8 HIS A  22
GLY A  11
ASN A  23
TYR A  17
 HIS  A  22 ( 1.0A)
GLY  A  11 ( 0.0A)
ASN  A  23 ( 0.6A)
TYR  A  17 ( 1.3A)
 1.40A 3ccfA-1rynA:
undetectable		 3ccfA-1rynA:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DCJ_B_THHB401_0
(PROBABLE
5'-PHOSPHORIBOSYLGLY
CINAMIDE
FORMYLTRANSFERASE
PURN)		 3kbb PHOSPHORYLATED
CARBOHYDRATES
PHOSPHATASE TM_1254
(Thermotoga
maritima) 		5 / 8 LEU A 123
LEU A  93
ASN A  86
THR A  15
VAL A  89
 LEU  A 123 ( 0.6A)
LEU  A  93 ( 0.6A)
ASN  A  86 ( 0.6A)
THR  A  15 ( 0.8A)
VAL  A  89 ( 0.6A)
 1.35A 3dcjB-3kbbA:
3.7		 3dcjB-3kbbA:
19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.06A 3dd1A-1omoA:
2.1		 3dd1A-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DD1_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.04A 3dd1B-1omoA:
undetectable		 3dd1B-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_A_CFFA904_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.07A 3ddsA-1omoA:
2.2		 3ddsA-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDS_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.05A 3ddsB-1omoA:
0.0		 3ddsB-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_A_CFFA903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.06A 3ddwA-1omoA:
2.4		 3ddwA-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDW_B_CFFB903_1
(GLYCOGEN
PHOSPHORYLASE, LIVER
FORM)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		4 / 6 ASN A 214
PHE A 288
ALA A 117
GLY A 114
 ASN  A 214 ( 0.6A)
PHE  A 288 ( 1.3A)
ALA  A 117 ( 0.0A)
GLY  A 114 ( 0.0A)
 1.05A 3ddwB-1omoA:
undetectable		 3ddwB-1omoA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DDY_A_RBFA187_1
(LUMAZINE PROTEIN)		 6cgu CADHERIN-6
(Mus
musculus) 		5 / 12 THR A 198
ILE A 148
GLN A 150
ASN A 202
ILE A 203
 THR  A 198 ( 0.8A)
ILE  A 148 ( 0.6A)
GLN  A 150 ( 0.6A)
ASN  A 202 ( 0.6A)
ILE  A 203 ( 0.7A)
 1.10A 3ddyA-6cguA:
undetectable		 3ddyA-6cguA:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E23_A_SAMA221_1
(UNCHARACTERIZED
PROTEIN RPA2492)		 12as ASPARAGINE
SYNTHETASE
(Escherichia
coli) 		3 / 3 TYR A 218
ASP A 118
HIS A  71
 ASN  A 331 (-4.3A)
ASN  A 331 (-3.3A)
None
 0.73A 3e23A-12asA:
undetectable		 3e23A-12asA:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E9R_A_ACTA700_0
(PURINE-NUCLEOSIDE
PHOSPHORYLASE)		 1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii) 		4 / 6 GLY A 117
TYR A 317
GLY A 119
ASN A 116
 GLY  A 117 ( 0.0A)
TYR  A 317 ( 1.3A)
GLY  A 119 ( 0.0A)
ASN  A 116 ( 0.6A)
 1.08A 3e9rA-1wqaA:
undetectable		 3e9rA-1wqaA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E9R_C_ACTC700_0
(PURINE-NUCLEOSIDE
PHOSPHORYLASE)		 1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii) 		4 / 6 GLY A 117
TYR A 317
GLY A 119
ASN A 116
 GLY  A 117 ( 0.0A)
TYR  A 317 ( 1.3A)
GLY  A 119 ( 0.0A)
ASN  A 116 ( 0.6A)
 1.09A 3e9rC-1wqaA:
undetectable		 3e9rC-1wqaA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_C_SAMC300_1
(PUTATIVE RRNA
METHYLASE)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		3 / 3 ASN A 305
ASP A 332
GLN A 330
 ASN  A 305 (-0.6A)
ASP  A 332 ( 0.5A)
GLN  A 330 ( 0.6A)
 0.81A 3eeyC-4mwtA:
undetectable		 3eeyC-4mwtA:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_C_SAMC300_1
(PUTATIVE RRNA
METHYLASE)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		3 / 3 ASN A 366
ASP A 378
GLN A 320
 ASN  A 366 ( 0.6A)
ASP  A 378 ( 0.6A)
GLN  A 320 ( 0.6A)
 0.84A 3eeyC-5hiuA:
undetectable		 3eeyC-5hiuA:
18.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_D_SAMD300_1
(PUTATIVE RRNA
METHYLASE)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		3 / 3 ASN A 305
ASP A 332
GLN A 330
 ASN  A 305 (-0.6A)
ASP  A 332 ( 0.5A)
GLN  A 330 ( 0.6A)
 0.80A 3eeyD-4mwtA:
undetectable		 3eeyD-4mwtA:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_E_SAME300_1
(PUTATIVE RRNA
METHYLASE)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		3 / 3 ASN A 305
ASP A 332
GLN A 330
 ASN  A 305 (-0.6A)
ASP  A 332 ( 0.5A)
GLN  A 330 ( 0.6A)
 0.80A 3eeyE-4mwtA:
undetectable		 3eeyE-4mwtA:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_E_SAME300_1
(PUTATIVE RRNA
METHYLASE)		 5hiu GTPASE
ACTIVATOR-LIKE
PROTEIN
(Chaetomium
thermophilum) 		3 / 3 ASN A 366
ASP A 378
GLN A 320
 ASN  A 366 ( 0.6A)
ASP  A 378 ( 0.6A)
GLN  A 320 ( 0.6A)
 0.82A 3eeyE-5hiuA:
undetectable		 3eeyE-5hiuA:
18.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ELZ_A_CHDA151_0
(ILEAL BILE
ACID-BINDING PROTEIN)		 3h0l GLUTAMYL-TRNA(GLN)
AMIDOTRANSFERASE
SUBUNIT A
(Aquifex
aeolicus) 		4 / 7 TYR A 302
GLY A 169
TYR A 188
ARG A 375
 ASN  A 901 (-4.6A)
ASN  A 901 (-3.8A)
None
None
 0.86A 3elzA-3h0lA:
0.0		 3elzA-3h0lA:
13.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ELZ_B_CHDB152_0
(ILEAL BILE
ACID-BINDING PROTEIN)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		3 / 3 ASN A 728
HIS A 678
VAL A 719
 ASN  A 728 ( 0.6A)
HIS  A 678 ( 1.0A)
VAL  A 719 ( 0.6A)
 0.82A 3elzB-4zkeA:
undetectable		 3elzB-4zkeA:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EYG_A_MI1A1_1
(TYROSINE-PROTEIN
KINASE)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		9 / 12 GLY A  32
GLY A  34
GLY A  37
VAL A  39
LYS A  54
SER A 112
ASN A 158
LEU A 160
ASP A 171
 GLY  A  32 ( 0.0A)
GLY  A  34 ( 0.0A)
GLY  A  37 ( 0.0A)
VAL  A  39 (-0.6A)
LYS  A  54 ( 0.0A)
SER  A 112 (-0.0A)
ASN  A 158 ( 0.6A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
 0.94A 3eygA-5d7aA:
24.2		 3eygA-5d7aA:
27.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EYG_A_MI1A1_1
(TYROSINE-PROTEIN
KINASE)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		9 / 12 GLY A  32
GLY A  37
VAL A  39
ALA A  52
LYS A  54
SER A 112
ASN A 158
LEU A 160
ASP A 171
 GLY  A  32 ( 0.0A)
GLY  A  37 ( 0.0A)
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
SER  A 112 (-0.0A)
ASN  A 158 ( 0.6A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
 0.71A 3eygA-5d7aA:
24.2		 3eygA-5d7aA:
27.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_A_ROFA901_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		10 / 12 TYR A 159
HIS A 160
ASN A 321
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
MET A 357
SER A 368
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
 0.52A 3g4lA-3sl5A:
53.4		 3g4lA-3sl5A:
98.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_A_ROFA901_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		11 / 12 TYR A 159
HIS A 160
MET A 273
ASN A 321
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
SER A 368
PHE A 372
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
 0.44A 3g4lA-3sl5A:
53.4		 3g4lA-3sl5A:
98.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3G4L_C_ROFC903_0
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		12 / 12 TYR A 159
HIS A 160
MET A 273
ASP A 318
LEU A 319
ASN A 321
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
MET A 357
 TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
 0.46A 3g4lC-3sl5A:
53.0		 3g4lC-3sl5A:
98.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3I9J_B_NCAB302_0
(ADP-RIBOSYL CYCLASE)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 6 GLU A 157
ASN A 187
SER A 259
PHE A 151
 GLU  A 157 ( 0.5A)
ASN  A 187 ( 0.6A)
SER  A 259 ( 0.0A)
PHE  A 151 ( 1.3A)
 1.49A 3i9jB-4hneA:
undetectable		 3i9jB-4hneA:
20.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IAK_A_EV1A415_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		8 / 9 TYR A 159
ASN A 321
ILE A 336
PHE A 340
MET A 357
GLN A 369
PHE A 372
ILE A 376
 TYR  A 159 (-1.3A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
ILE  A 376 (-0.6A)
 0.53A 3iakA-3sl5A:
51.9		 3iakA-3sl5A:
94.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IAK_A_EV1A415_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		8 / 9 TYR A 159
MET A 273
ASN A 321
ILE A 336
PHE A 340
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.73A 3iakA-3sl5A:
51.9		 3iakA-3sl5A:
94.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JB2_A_SAMA1101_0
(STRUCTURAL PROTEIN
VP3)		 2qc5 STREPTOGRAMIN B
LACTONASE
(Staphylococcus
cohnii) 		5 / 12 ASN A 138
SER A 141
GLU A 175
PRO A 137
GLU A 217
 ASN  A 138 ( 0.6A)
SER  A 141 ( 0.0A)
GLU  A 175 ( 0.6A)
PRO  A 137 ( 1.1A)
GLU  A 217 ( 0.6A)
 1.46A 3jb2A-2qc5A:
undetectable		 3jb2A-2qc5A:
14.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JW2_A_017A401_1
(GAG-POL POLYPROTEIN)		 12as ASPARAGINE
SYNTHETASE
(Escherichia
coli) 		6 / 12 LEU A 237
ASP A 235
ASP A 219
VAL A 199
ILE A 140
VAL A 196
 None
None
ASN  A 331 ( 3.9A)
None
None
None
 1.49A 3jw2A-12asA:
undetectable		 3jw2A-12asA:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_A_THHA642_1
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)		 3r9r PHOSPHORIBOSYLAMINOI
MIDAZOLE-SUCCINOCARB
OXAMIDE SYNTHASE
(Mycobacteroides
abscessus) 		3 / 3 ASN A 154
ASP A 152
ARG A 244
 ASN  A 154 ( 0.6A)
ASP  A 152 ( 0.6A)
ARG  A 244 ( 0.6A)
 0.83A 3k13A-3r9rA:
undetectable		 3k13A-3r9rA:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K39_D_BCZD1001_0
(NEURAMINIDASE)		 6h20 -
(-) 		5 / 12 LEU A 180
ASP A 250
ALA A 208
ARG A 147
ARG A 169
 None
ASN  A 401 (-2.9A)
None
ASN  A 401 (-3.0A)
ASN  A 401 (-2.9A)
 1.40A 3k39D-6h20A:
undetectable		 3k39D-6h20A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KP2_B_PNNB5002_0
(TRANSCRIPTIONAL
REGULATOR TCAR)		 2hk0 D-PSICOSE
3-EPIMERASE
(Agrobacterium
tumefaciens) 		4 / 5 ASN A 177
ALA A 140
ALA A 137
LYS A  86
 ASN  A 177 ( 0.6A)
ALA  A 140 ( 0.0A)
ALA  A 137 ( 0.0A)
LYS  A  86 ( 0.0A)
 1.41A 3kp2B-2hk0A:
undetectable		 3kp2B-2hk0A:
19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KP5_A_KANA2001_1
(TRANSCRIPTIONAL
REGULATOR TCAR)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		5 / 11 VAL A 128
ALA A 118
GLU A  73
ASN A 113
ARG A 169
 VAL  A 128 ( 0.6A)
ALA  A 118 ( 0.0A)
GLU  A  73 ( 0.5A)
ASN  A 113 ( 0.6A)
ARG  A 169 ( 0.6A)
 1.41A 3kp5A-3gnrA:
undetectable		 3kp5A-3gnrA:
16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPB_A_SAMA1000_0
(UNCHARACTERIZED
PROTEIN MJ0100)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		5 / 12 ASN A 362
ILE A  51
VAL A 394
ILE A 393
ILE A 385
 ASN  A 362 ( 0.6A)
ILE  A  51 ( 0.7A)
VAL  A 394 ( 0.6A)
ILE  A 393 ( 0.4A)
ILE  A 385 ( 0.7A)
 1.16A 3kpbA-4kqnA:
undetectable		 3kpbA-4kqnA:
14.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPC_A_SAMA1000_0
(UNCHARACTERIZED
PROTEIN MJ0100)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		5 / 11 ILE A 396
THR A  62
VAL A 374
ILE A 373
ASN A 370
 ILE  A 396 ( 0.7A)
THR  A  62 ( 0.8A)
VAL  A 374 ( 0.5A)
ILE  A 373 ( 0.7A)
ASN  A 370 ( 0.6A)
 1.25A 3kpcA-2vbfA:
undetectable		 3kpcA-2vbfA:
12.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPD_B_SAMB1000_1
(UNCHARACTERIZED
PROTEIN MJ0100)		 5wo6 TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 6
(Rattus
norvegicus) 		3 / 3 ASN A  57
ASN A  91
GLU A  93
 ASN  A  57 ( 0.6A)
ASN  A  91 ( 0.6A)
GLU  A  93 ( 0.6A)
 0.88A 3kpdC-5wo6A:
undetectable		 3kpdC-5wo6A:
9.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPD_C_SAMC1000_0
(UNCHARACTERIZED
PROTEIN MJ0100)		 1l4a S-SNAP25 FUSION
PROTEIN
S-SNAP25 FUSION
PROTEIN
(Doryteuthis
pealeii;
Doryteuthis
pealeii) 		3 / 3 ASN C  37
ASN D 156
GLU D 159
 ASN  C  37 ( 0.6A)
ASN  D 156 ( 0.6A)
GLU  D 159 ( 0.6A)
 0.91A 3kpdB-1l4aC:
undetectable		 3kpdB-1l4aC:
18.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LM8_C_VIBC223_1
(THIAMINE
PYROPHOSPHOKINASE)		 5e37 EF-HAND
DOMAIN-CONTAINING
THIOREDOXIN
(Chlamydomonas
reinhardtii) 		4 / 8 ASP A 102
LEU A 104
SER A 176
ASN A 175
 ASP  A 102 ( 0.5A)
LEU  A 104 ( 0.6A)
SER  A 176 ( 0.0A)
ASN  A 175 ( 0.6A)
 0.98A 3lm8A-5e37A:
undetectable
3lm8C-5e37A:
undetectable		 3lm8A-5e37A:
21.21
3lm8C-5e37A:
21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MEK_A_SAMA510_0
(SET AND MYND
DOMAIN-CONTAINING
PROTEIN 3)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 GLY A 222
ASN A 223
TYR A 202
HIS A 248
TYR A 240
 GLY  A 222 ( 0.0A)
ASN  A 223 ( 0.6A)
TYR  A 202 ( 1.3A)
HIS  A 248 ( 1.0A)
TYR  A 240 ( 1.3A)
 1.32A 3mekA-5nqfA:
undetectable		 3mekA-5nqfA:
20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N23_C_OBNC1_1
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		5 / 11 ASP A  88
ASN A  86
LEU A  89
VAL A  77
ALA A  76
 ASP  A  88 ( 0.5A)
ASN  A  86 ( 0.6A)
LEU  A  89 ( 0.6A)
VAL  A  77 ( 0.6A)
ALA  A  76 ( 0.0A)
 1.24A 3n23C-2nvvA:
undetectable		 3n23C-2nvvA:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_B_1N1B2000_1
(P38A)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 10 ILE A  96
ILE A 143
ILE A 136
ASN A 104
VAL A  43
 ILE  A  96 ( 0.7A)
ILE  A 143 ( 0.7A)
ILE  A 136 ( 0.7A)
ASN  A 104 ( 0.6A)
VAL  A  43 ( 0.6A)
 1.24A 3ohtA-3ulkA:
undetectable
3ohtB-3ulkA:
undetectable		 3ohtA-3ulkA:
22.80
3ohtB-3ulkA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OI8_A_ADNA2_1
(UNCHARACTERIZED
PROTEIN)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		4 / 6 ILE A 655
ASN A 727
HIS A 678
LEU A 657
 ILE  A 655 ( 0.7A)
ASN  A 727 ( 0.6A)
HIS  A 678 ( 1.0A)
LEU  A 657 ( 0.6A)
 0.97A 3oi8A-4zkeA:
undetectable		 3oi8A-4zkeA:
15.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P2K_C_SAMC6735_1
(16S RRNA METHYLASE)		 5ve2 ENOYL-COA HYDRATASE
(Pseudoalteromona
s
atlantica) 		4 / 5 ASN A  43
GLU A 137
THR A 109
SER A  42
 ASN  A  43 ( 0.6A)
GLU  A 137 ( 0.6A)
THR  A 109 ( 0.8A)
SER  A  42 (-0.0A)
 1.14A 3p2kC-5ve2A:
undetectable		 3p2kC-5ve2A:
24.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PGL_A_RZXA257_1
(CARBOXY-TERMINAL
DOMAIN RNA
POLYMERASE II
POLYPEPTIDE A SMALL
PHOSPHATASE 1)		 6h20 -
(-) 		4 / 7 ASP A 250
SER A 164
TYR A 276
ARG A 169
 ASN  A 401 (-2.9A)
ASN  A 401 (-2.9A)
ASN  A 401 ( 4.9A)
ASN  A 401 (-2.9A)
 0.99A 3pglA-6h20A:
undetectable		 3pglA-6h20A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PWW_A_ROCA1001_1
(ENDOTHIAPEPSIN)		 3h0l GLUTAMYL-TRNA(GLN)
AMIDOTRANSFERASE
SUBUNIT A
(Aquifex
aeolicus) 		5 / 12 ILE A 299
ASP A 418
PHE A 276
ILE A 436
THR A 396
 None
ASN  A 901 (-3.2A)
None
None
None
 0.98A 3pwwA-3h0lA:
undetectable		 3pwwA-3h0lA:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QG2_B_CP6B709_1
(BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE)		 2an1 PUTATIVE KINASE
(Salmonella
enterica) 		5 / 11 ILE A 146
ASN A 268
ILE A  88
LEU A 267
THR A 144
 ILE  A 146 ( 0.7A)
ASN  A 268 ( 0.6A)
ILE  A  88 ( 0.7A)
LEU  A 267 ( 0.6A)
THR  A 144 ( 0.8A)
 1.17A 3qg2B-2an1A:
undetectable		 3qg2B-2an1A:
19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ROD_D_NCAD302_0
(NICOTINAMIDE
N-METHYLTRANSFERASE)		 6h20 -
(-) 		4 / 7 ASP A 181
ALA A 182
ASP A 273
TYR A 276
 None
None
None
ASN  A 401 ( 4.9A)
 1.16A 3rodD-6h20A:
undetectable		 3rodD-6h20A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S68_A_SAMA228_1
(CATECHOL
O-METHYLTRANSFERASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 ASN A 293
VAL A 294
MET A 224
ASN A 225
HIS A 220
 ASN  A 293 ( 0.6A)
VAL  A 294 ( 0.6A)
MET  A 224 ( 0.0A)
ASN  A 225 ( 0.6A)
HIS  A 220 ( 1.0A)
 1.48A 3s68A-5nqfA:
undetectable		 3s68A-5nqfA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SFU_A_RBVA601_1
(RNA POLYMERASE)		 4mtp RNA DEPENDENT RNA
POLYMERASE
(Japanese
encephalitis
virus) 		5 / 9 ASP A 541
ASN A 613
GLY A 667
ASP A 668
ASP A 669
 ASP  A 541 ( 0.6A)
ASN  A 613 ( 0.6A)
GLY  A 667 ( 0.0A)
ASP  A 668 ( 0.6A)
ASP  A 669 ( 0.6A)
 1.06A 3sfuA-4mtpA:
19.2		 3sfuA-4mtpA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SFU_A_RBVA601_1
(RNA POLYMERASE)		 4mtp RNA DEPENDENT RNA
POLYMERASE
(Japanese
encephalitis
virus) 		5 / 9 ASP A 541
SER A 604
ASN A 613
GLY A 667
ASP A 668
 ASP  A 541 ( 0.6A)
SER  A 604 ( 0.0A)
ASN  A 613 ( 0.6A)
GLY  A 667 ( 0.0A)
ASP  A 668 ( 0.6A)
 1.04A 3sfuA-4mtpA:
19.2		 3sfuA-4mtpA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SFU_B_RBVB601_1
(RNA POLYMERASE)		 4mtp RNA DEPENDENT RNA
POLYMERASE
(Japanese
encephalitis
virus) 		5 / 9 ASP A 541
ASN A 613
GLY A 667
ASP A 668
ASP A 669
 ASP  A 541 ( 0.6A)
ASN  A 613 ( 0.6A)
GLY  A 667 ( 0.0A)
ASP  A 668 ( 0.6A)
ASP  A 669 ( 0.6A)
 1.01A 3sfuB-4mtpA:
21.6		 3sfuB-4mtpA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SFU_C_RBVC601_1
(RNA POLYMERASE)		 4mtp RNA DEPENDENT RNA
POLYMERASE
(Japanese
encephalitis
virus) 		5 / 11 ASP A 541
SER A 604
ASN A 613
GLY A 667
ASP A 668
 ASP  A 541 ( 0.6A)
SER  A 604 ( 0.0A)
ASN  A 613 ( 0.6A)
GLY  A 667 ( 0.0A)
ASP  A 668 ( 0.6A)
 1.04A 3sfuC-4mtpA:
19.6		 3sfuC-4mtpA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SFU_C_RBVC601_1
(RNA POLYMERASE)		 4mtp RNA DEPENDENT RNA
POLYMERASE
(Japanese
encephalitis
virus) 		5 / 11 ASP A 541
SER A 604
THR A 609
ASN A 613
GLY A 667
 ASP  A 541 ( 0.6A)
SER  A 604 ( 0.0A)
THR  A 609 ( 0.8A)
ASN  A 613 ( 0.6A)
GLY  A 667 ( 0.0A)
 1.11A 3sfuC-4mtpA:
19.6		 3sfuC-4mtpA:
22.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TVX_A_PNXA902_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4A)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		9 / 9 TYR A 159
LEU A 319
ASN A 321
PRO A 322
THR A 333
ILE A 336
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
LEU  A 319 ( 0.6A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.46A 3tvxA-3sl5A:
51.5		 3tvxA-3sl5A:
85.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TVX_B_PNXB902_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4A)		 3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens) 		7 / 7 TYR A 159
ASN A 321
ILE A 336
PHE A 340
MET A 357
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
ASN  A 321 (-0.6A)
ILE  A 336 ( 0.4A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.52A 3tvxB-3sl5A:
51.6		 3tvxB-3sl5A:
85.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TWP_A_SALA404_1
(ANTHRANILATE
PHOSPHORIBOSYLTRANSF
ERASE)		 4c9g ADP, ATP CARRIER
PROTEIN 2
(Saccharomyces
cerevisiae) 		4 / 7 ASN A  93
ALA A  92
ARG A 154
ALA A 156
 ASN  A  93 ( 0.6A)
ALA  A  92 ( 0.0A)
ARG  A 154 ( 0.6A)
ALA  A 156 ( 0.0A)
 0.91A 3twpA-4c9gA:
undetectable		 3twpA-4c9gA:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TWP_A_SALA404_1
(ANTHRANILATE
PHOSPHORIBOSYLTRANSF
ERASE)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 7 ASN A 249
ALA A 237
ALA A  97
ARG A 101
 ASN  A 249 ( 0.6A)
ALA  A 237 ( 0.0A)
ALA  A  97 ( 0.0A)
ARG  A 101 ( 0.6A)
 0.80A 3twpA-4hneA:
undetectable		 3twpA-4hneA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TWP_B_SALB404_1
(ANTHRANILATE
PHOSPHORIBOSYLTRANSF
ERASE)		 4c9g ADP, ATP CARRIER
PROTEIN 2
(Saccharomyces
cerevisiae) 		4 / 7 ASN A  93
ALA A  92
ARG A 154
ALA A 156
 ASN  A  93 ( 0.6A)
ALA  A  92 ( 0.0A)
ARG  A 154 ( 0.6A)
ALA  A 156 ( 0.0A)
 0.97A 3twpB-4c9gA:
undetectable		 3twpB-4c9gA:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TWP_B_SALB404_1
(ANTHRANILATE
PHOSPHORIBOSYLTRANSF
ERASE)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 7 ASN A 249
ALA A 237
ALA A  97
ARG A 101
 ASN  A 249 ( 0.6A)
ALA  A 237 ( 0.0A)
ALA  A  97 ( 0.0A)
ARG  A 101 ( 0.6A)
 0.75A 3twpB-4hneA:
undetectable		 3twpB-4hneA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TWP_C_SALC404_1
(ANTHRANILATE
PHOSPHORIBOSYLTRANSF
ERASE)		 4c9g ADP, ATP CARRIER
PROTEIN 2
(Saccharomyces
cerevisiae) 		4 / 7 ASN A  93
ALA A  92
ARG A 154
ALA A 156
 ASN  A  93 ( 0.6A)
ALA  A  92 ( 0.0A)
ARG  A 154 ( 0.6A)
ALA  A 156 ( 0.0A)
 1.10A 3twpC-4c9gA:
undetectable		 3twpC-4c9gA:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TWP_C_SALC404_1
(ANTHRANILATE
PHOSPHORIBOSYLTRANSF
ERASE)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 7 ASN A 249
ALA A 237
ALA A  97
ARG A 101
 ASN  A 249 ( 0.6A)
ALA  A 237 ( 0.0A)
ALA  A  97 ( 0.0A)
ARG  A 101 ( 0.6A)
 0.76A 3twpC-4hneA:
undetectable		 3twpC-4hneA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UQ6_A_ADNA401_2
(ADENOSINE KINASE,
PUTATIVE)		 2dj6 HYPOTHETICAL PROTEIN
PH0634
(Pyrococcus
horikoshii) 		4 / 5 LEU A  63
ALA A  13
PHE A  31
ASN A  69
 LEU  A  63 ( 0.5A)
ALA  A  13 ( 0.0A)
PHE  A  31 ( 1.3A)
ASN  A  69 ( 0.6A)
 1.44A 3uq6A-2dj6A:
undetectable		 3uq6A-2dj6A:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_A_T1CA404_1
(TETX2 PROTEIN)		 4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima) 		5 / 12 GLY A 167
ALA A 128
GLY A 129
ASN A 210
MET A 234
 GLY  A 167 ( 0.0A)
ALA  A 128 ( 0.0A)
GLY  A 129 ( 0.0A)
ASN  A 210 ( 0.6A)
MET  A 234 ( 0.0A)
 1.23A 3v3oA-4ursA:
undetectable		 3v3oA-4ursA:
19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_B_T1CB405_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 12 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.11A 3v3oB-5gprA:
undetectable		 3v3oB-5gprA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V3O_D_T1CD401_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 10 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.18A 3v3oD-5gprA:
undetectable		 3v3oD-5gprA:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V4T_A_ACTA505_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)		 3h7a SHORT CHAIN
DEHYDROGENASE
(Rhodopseudomonas
palustris) 		3 / 3 THR A  70
ASN A  74
GLU A 122
 THR  A  70 ( 0.8A)
ASN  A  74 ( 0.6A)
GLU  A 122 ( 0.6A)
 0.69A 3v4tA-3h7aA:
undetectable
3v4tC-3h7aA:
0.3		 3v4tA-3h7aA:
20.29
3v4tC-3h7aA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V4T_D_ACTD502_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)		 1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii) 		3 / 3 GLY A 210
THR A  50
ASN A 183
 GLY  A 210 ( 0.0A)
THR  A  50 ( 0.8A)
ASN  A 183 ( 0.6A)
 0.62A 3v4tD-1wqaA:
undetectable		 3v4tD-1wqaA:
24.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V4T_E_ACTE503_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)		 1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii) 		3 / 3 GLN A 207
THR A  50
ASN A 183
 GLN  A 207 ( 0.6A)
THR  A  50 ( 0.8A)
ASN  A 183 ( 0.6A)
 0.90A 3v4tE-1wqaA:
undetectable		 3v4tE-1wqaA:
24.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V8V_A_SAMA801_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE L)		 5dne L-ASPARAGINASE
(Cavia
porcellus) 		5 / 12 PRO A 145
ILE A 146
GLY A  18
ASP A 117
LEU A 174
 None
None
ASN  A 601 (-3.5A)
ASN  A 601 (-3.0A)
None
 1.20A 3v8vA-5dneA:
undetectable		 3v8vA-5dneA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V8V_A_SAMA801_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE L)		 5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE
(Bacillus
licheniformis) 		5 / 12 ILE A  87
THR A 224
ASN A  78
PRO A  82
LEU A 183
 ILE  A  87 ( 0.6A)
THR  A 224 ( 0.8A)
ASN  A  78 ( 0.6A)
PRO  A  82 ( 1.1A)
LEU  A 183 ( 0.6A)
 1.20A 3v8vA-5xluA:
undetectable		 3v8vA-5xluA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAQ_A_ADNA401_2
(PUTATIVE ADENOSINE
KINASE)		 2dj6 HYPOTHETICAL PROTEIN
PH0634
(Pyrococcus
horikoshii) 		4 / 4 LEU A  63
ALA A  13
PHE A  31
ASN A  69
 LEU  A  63 ( 0.5A)
ALA  A  13 ( 0.0A)
PHE  A  31 ( 1.3A)
ASN  A  69 ( 0.6A)
 1.49A 3vaqA-2dj6A:
undetectable		 3vaqA-2dj6A:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VT3_A_VDXA500_1
(VITAMIN D3 RECEPTOR)		 12as ASPARAGINE
SYNTHETASE
(Escherichia
coli) 		5 / 12 LEU A  48
SER A  72
SER A 251
LEU A 265
HIS A 279
 None
ASN  A 331 (-2.9A)
AMP  A 332 ( 3.0A)
None
None
 1.49A 3vt3A-12asA:
0.0		 3vt3A-12asA:
20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W37_A_ACRA1001_1
(ALPHA-GLUCOSIDASE)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		5 / 12 ASN A  95
ASP A 413
ILE A 376
ASP A 102
HIS A 411
 ASN  A  95 ( 0.6A)
ASP  A 413 (-0.5A)
ILE  A 376 ( 0.7A)
ASP  A 102 ( 0.6A)
HIS  A 411 (-1.0A)
 1.29A 3w37A-2nvvA:
undetectable		 3w37A-2nvvA:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_B_W9TB504_1
(HEMOLYTIC LECTIN
CEL-III)		 12as ASPARAGINE
SYNTHETASE
(Escherichia
coli) 		4 / 5 ASP A 118
GLU A 120
GLY A 293
GLN A 116
 ASN  A 331 (-3.3A)
None
ASN  A 331 (-4.0A)
ASN  A 331 ( 3.5A)
 1.38A 3w9tB-12asA:
0.0		 3w9tB-12asA:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WEL_A_ACRA1001_1
(ALPHA-GLUCOSIDASE)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		5 / 12 ASN A  95
ASP A 413
ILE A 376
ASP A 102
HIS A 411
 ASN  A  95 ( 0.6A)
ASP  A 413 (-0.5A)
ILE  A 376 ( 0.7A)
ASP  A 102 ( 0.6A)
HIS  A 411 (-1.0A)
 1.29A 3welA-2nvvA:
undetectable		 3welA-2nvvA:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_A_T1CA392_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.13A 4a6nA-5gprA:
undetectable		 4a6nA-5gprA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_B_T1CB392_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.13A 4a6nB-5gprA:
undetectable		 4a6nB-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A6N_C_T1CC392_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.13A 4a6nC-5gprA:
undetectable		 4a6nC-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A7T_A_5FWA1002_1
(SUPEROXIDE DISMUTASE
[CU-ZN])		 4oud TYROSYL-TRNA
SYNTHETASE
(Escherichia
coli) 		3 / 3 ASN B 126
TRP B 129
ASP B  41
 ASN  B 126 ( 0.6A)
TRP  B 129 ( 0.5A)
ASP  B  41 ( 0.6A)
 0.80A 4a7tA-4oudB:
undetectable
4a7tF-4oudB:
undetectable		 4a7tA-4oudB:
18.31
4a7tF-4oudB:
18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_A_MIYA391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 10 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.22A 4a99A-5gprA:
undetectable		 4a99A-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_B_MIYB391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.19A 4a99B-5gprA:
undetectable		 4a99B-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_C_MIYC391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.21A 4a99C-5gprA:
undetectable		 4a99C-5gprA:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_D_MIYD391_1
(TETX2 PROTEIN)		 5gpr CHITINASE
(Ostrinia
furnacalis) 		5 / 11 PHE A 309
ASN A 316
GLY A 312
GLY A 266
MET A 381
 PHE  A 309 ( 1.3A)
ASN  A 316 ( 0.6A)
GLY  A 312 ( 0.0A)
GLY  A 266 ( 0.0A)
MET  A 381 ( 0.0A)
 1.21A 4a99D-5gprA:
undetectable		 4a99D-5gprA:
22.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4AGA_A_ACTA1131_0
(LYSOZYME C)		 3cb7 LYS-RICH LYSOZYME 2
(Musca
domestica) 		3 / 3 ASN A  48
ASP A  54
ASN A  61
 ASN  A  48 ( 0.6A)
ASP  A  54 (-0.5A)
ASN  A  61 (-0.6A)
 0.39A 4agaA-3cb7A:
19.0		 4agaA-3cb7A:
37.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BBO_C_ACTC1113_0
(BLR5658 PROTEIN)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		4 / 4 ASN A  93
ALA A  95
GLY A  96
THR A 254
 ASN  A  93 ( 0.6A)
ALA  A  95 ( 0.0A)
GLY  A  96 ( 0.0A)
THR  A 254 ( 0.8A)
 1.16A 4bboC-1wsvA:
undetectable		 4bboC-1wsvA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BBO_C_ACTC1113_0
(BLR5658 PROTEIN)		 1wsv AMINOMETHYLTRANSFERA
SE
(Homo
sapiens) 		4 / 4 ASN A  93
ALA A  95
GLY A  97
THR A 254
 ASN  A  93 ( 0.6A)
ALA  A  95 ( 0.0A)
GLY  A  97 ( 0.0A)
THR  A 254 ( 0.8A)
 1.39A 4bboC-1wsvA:
undetectable		 4bboC-1wsvA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CLA_A_CLMA221_0
(TYPE III
CHLORAMPHENICOL
ACETYLTRANSFERASE)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		5 / 11 GLN A 139
THR A 141
ALA A 144
LEU A  49
ASN A 136
 GLN  A 139 ( 0.6A)
THR  A 141 ( 0.8A)
ALA  A 144 ( 0.0A)
LEU  A  49 ( 0.6A)
ASN  A 136 ( 0.6A)
 1.24A 4claA-3r6yA:
undetectable		 4claA-3r6yA:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CP3_B_RBTB1129_1
(B-CELL LYMPHOMA 6
PROTEIN)		 3c3n DIHYDROOROTATE
DEHYDROGENASE
(Trypanosoma
cruzi) 		4 / 7 ASN A 129
ARG A  52
GLY A  22
SER A  26
 ASN  A 129 (-0.6A)
ARG  A  52 ( 0.6A)
GLY  A  22 (-0.0A)
SER  A  26 ( 0.0A)
 0.77A 4cp3A-3c3nA:
undetectable
4cp3B-3c3nA:
undetectable		 4cp3A-3c3nA:
20.77
4cp3B-3c3nA:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1Y_A_RBFA1176_1
(PUTATIVE PROTEASE I)		 6h20 -
(-) 		4 / 8 GLN A 184
GLN A 274
LYS A 161
THR A 162
 None
ASN  A 401 ( 4.8A)
None
ASN  A 401 (-3.8A)
 1.20A 4d1yA-6h20A:
undetectable
4d1yB-6h20A:
undetectable		 4d1yA-6h20A:
undetectable
4d1yB-6h20A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAJ_B_0HKB2000_1
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR M3,
LYSOZYME)		 6h20 -
(-) 		5 / 12 SER A 102
THR A 212
THR A 211
ALA A 144
TYR A 276
 None
ASN  A 401 (-3.5A)
ASN  A 401 (-4.0A)
ASN  A 401 ( 4.3A)
ASN  A 401 ( 4.9A)
 1.13A 4dajB-6h20A:
0.2		 4dajB-6h20A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJJ_D_NCTD501_1
(CYTOCHROME P450 2A6)		 2qc5 STREPTOGRAMIN B
LACTONASE
(Staphylococcus
cohnii) 		4 / 7 ASN A 138
ILE A 122
LEU A 173
PHE A 156
 ASN  A 138 ( 0.6A)
ILE  A 122 ( 0.7A)
LEU  A 173 ( 0.6A)
PHE  A 156 ( 1.3A)
 0.80A 4ejjD-2qc5A:
undetectable		 4ejjD-2qc5A:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGK_A_0TXA304_0
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 2hk0 D-PSICOSE
3-EPIMERASE
(Agrobacterium
tumefaciens) 		5 / 10 GLY A 106
GLY A 105
ASN A 157
VAL A 159
PHE A  89
 GLY  A 106 ( 0.0A)
GLY  A 105 ( 0.0A)
ASN  A 157 ( 0.6A)
VAL  A 159 ( 0.6A)
PHE  A  89 ( 1.3A)
 1.49A 4fgkA-2hk0A:
0.6
4fgkB-2hk0A:
undetectable		 4fgkA-2hk0A:
21.64
4fgkB-2hk0A:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGL_C_CLQC303_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 5w0a GLUCANASE
(Trichoderma
harzianum) 		4 / 8 ASN A 142
GLY A 143
PHE A 130
ILE A 199
 ASN  A 142 ( 0.6A)
GLY  A 143 ( 0.0A)
PHE  A 130 ( 1.3A)
ILE  A 199 ( 0.7A)
 0.93A 4fglD-5w0aA:
undetectable		 4fglD-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FR0_A_SAMA401_0
(ARSENIC
METHYLTRANSFERASE)		 5w0a GLUCANASE
(Trichoderma
harzianum) 		5 / 12 GLY A 140
LEU A 330
ILE A 319
ASN A 352
LEU A 134
 GLY  A 140 ( 0.0A)
LEU  A 330 ( 0.5A)
ILE  A 319 ( 0.7A)
ASN  A 352 ( 0.6A)
LEU  A 134 ( 0.6A)
 1.05A 4fr0A-5w0aA:
undetectable		 4fr0A-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4II8_A_010A210_0
(LYSOZYME C)		 2pk2 CYCLIN-T1, PROTEIN
TAT
(Homo
sapiens;
Equine
infectious
anemia
virus) 		4 / 7 ASP A  47
GLN A  50
ASN A  43
ILE A  63
 ASP  A  47 ( 0.6A)
GLN  A  50 ( 0.6A)
ASN  A  43 ( 0.6A)
ILE  A  63 ( 0.7A)
 1.23A 4ii8A-2pk2A:
undetectable		 4ii8A-2pk2A:
15.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4II8_A_010A210_0
(LYSOZYME C)		 3cb7 LYS-RICH LYSOZYME 2
(Musca
domestica) 		6 / 7 GLU A  36
ASP A  54
GLN A  59
ASN A  61
TRP A  65
TRP A 109
 GLU  A  36 (-0.6A)
ASP  A  54 (-0.5A)
GLN  A  59 (-0.6A)
ASN  A  61 (-0.6A)
TRP  A  65 (-0.5A)
TRP  A 109 ( 0.5A)
 0.32A 4ii8A-3cb7A:
19.0		 4ii8A-3cb7A:
37.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IPM_A_ACTA503_0
(GH7 FAMILY PROTEIN)		 5w0a GLUCANASE
(Trichoderma
harzianum) 		9 / 9 ASN A 142
ALA A 144
TYR A 146
TYR A 170
ASP A 172
GLU A 196
ASP A 198
GLU A 201
TRP A 320
 ASN  A 142 ( 0.6A)
ALA  A 144 ( 0.0A)
TYR  A 146 ( 1.3A)
TYR  A 170 ( 1.3A)
ASP  A 172 ( 0.5A)
GLU  A 196 ( 0.6A)
ASP  A 198 (-0.6A)
GLU  A 201 (-0.5A)
TRP  A 320 ( 0.5A)
 0.55A 4ipmA-5w0aA:
48.2		 4ipmA-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4J4V_C_SVRC301_1
(NUCLEOCAPSID PROTEIN)		 4yzr POLYKETIDE
BIOSYNTHESIS
CYTOCHROME P450 PKSS
(Bacillus
subtilis) 		4 / 8 GLY A 318
ASN A 321
ARG A 337
PRO A  17
 GLY  A 318 ( 0.0A)
ASN  A 321 ( 0.6A)
ARG  A 337 ( 0.6A)
PRO  A  17 ( 1.0A)
 0.94A 4j4vC-4yzrA:
2.5		 4j4vC-4yzrA:
19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JDS_C_SAMC401_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD7)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 11 ILE A 127
ALA A 346
GLY A 394
GLU A 120
ASN A 398
 ILE  A 127 ( 0.7A)
ALA  A 346 ( 0.0A)
GLY  A 394 ( 0.0A)
GLU  A 120 ( 0.5A)
ASN  A 398 ( 0.6A)
 1.13A 4jdsC-5nqfA:
undetectable		 4jdsC-5nqfA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JTP_A_ASCA802_0
(RRNA N-GLYCOSIDASE)		 3d9a HEAVY CHAIN OF
HYHEL10 ANTIBODY
FRAGMENT (FAB)
(Mus
musculus) 		4 / 5 TYR H 350
ASN H 360
TYR H 359
ILE H 369
 TYR  H 350 ( 1.3A)
ASN  H 360 ( 0.6A)
TYR  H 359 ( 1.3A)
ILE  H 369 ( 0.7A)
 1.00A 4jtpA-3d9aH:
undetectable		 4jtpA-3d9aH:
22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K0B_B_SAMB504_0
(S-ADENOSYLMETHIONINE
SYNTHASE)		 5cdn DNA GYRASE SUBUNIT A
(Staphylococcus
aureus) 		4 / 8 ASN A  54
ASP A  40
LEU A 160
ILE A 144
 ASN  A  54 ( 0.6A)
ASP  A  40 ( 0.5A)
LEU  A 160 ( 0.6A)
ILE  A 144 ( 0.4A)
 0.97A 4k0bA-5cdnA:
undetectable		 4k0bA-5cdnA:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K0B_B_SAMB504_0
(S-ADENOSYLMETHIONINE
SYNTHASE)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 8 ASN A 226
ARG A 209
ASP A 238
LEU A 235
 ASN  A 226 ( 0.6A)
ARG  A 209 ( 0.6A)
ASP  A 238 ( 0.5A)
LEU  A 235 ( 0.6A)
 0.99A 4k0bA-5d7wA:
undetectable		 4k0bA-5d7wA:
21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K0B_B_SAMB504_0
(S-ADENOSYLMETHIONINE
SYNTHASE)		 5l5n PLEXIN-A4
(Mus
musculus) 		4 / 8 ASN A 792
LEU A 721
ASN A 796
ILE A 709
 ASN  A 792 ( 0.6A)
LEU  A 721 ( 0.6A)
ASN  A 796 ( 0.6A)
ILE  A 709 ( 0.6A)
 0.93A 4k0bA-5l5nA:
undetectable		 4k0bA-5l5nA:
16.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCN_B_MTLB806_0
(NITRIC OXIDE
SYNTHASE, BRAIN)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		4 / 7 ASN A 406
GLN A 371
PHE A 369
ASN A 434
 ASN  A 406 ( 0.6A)
GLN  A 371 ( 0.6A)
PHE  A 369 ( 1.3A)
ASN  A 434 ( 0.6A)
 1.36A 4kcnB-4g9kA:
undetectable		 4kcnB-4g9kA:
20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOS_A_4KOA201_1
(UNCHARACTERIZED
PROTEIN)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 12 PRO A 372
TYR A 324
GLY A 346
ASN A 326
MET A 345
 PRO  A 372 ( 1.1A)
TYR  A 324 ( 1.3A)
GLY  A 346 ( 0.0A)
ASN  A 326 ( 0.6A)
MET  A 345 ( 0.0A)
 1.34A 4kosA-1v0fA:
undetectable		 4kosA-1v0fA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOV_A_KOVA204_1
(UNCHARACTERIZED
PROTEIN)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 12 PRO A 372
TYR A 324
GLY A 346
ASN A 326
MET A 345
 PRO  A 372 ( 1.1A)
TYR  A 324 ( 1.3A)
GLY  A 346 ( 0.0A)
ASN  A 326 ( 0.6A)
MET  A 345 ( 0.0A)
 1.36A 4kovA-1v0fA:
undetectable		 4kovA-1v0fA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOW_A_CFXA204_1
(UNCHARACTERIZED
PROTEIN)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 12 PRO A 372
TYR A 324
GLY A 346
ASN A 326
MET A 345
 PRO  A 372 ( 1.1A)
TYR  A 324 ( 1.3A)
GLY  A 346 ( 0.0A)
ASN  A 326 ( 0.6A)
MET  A 345 ( 0.0A)
 1.34A 4kowA-1v0fA:
0.0		 4kowA-1v0fA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOX_A_CLSA205_1
(UNCHARACTERIZED
PROTEIN)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 11 PRO A 372
TYR A 324
GLY A 346
ASN A 326
MET A 345
 PRO  A 372 ( 1.1A)
TYR  A 324 ( 1.3A)
GLY  A 346 ( 0.0A)
ASN  A 326 ( 0.6A)
MET  A 345 ( 0.0A)
 1.38A 4koxA-1v0fA:
0.0		 4koxA-1v0fA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOY_A_CSCA214_1
(UNCHARACTERIZED
PROTEIN)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		5 / 11 PRO A 372
TYR A 324
GLY A 346
ASN A 326
MET A 345
 PRO  A 372 ( 1.1A)
TYR  A 324 ( 1.3A)
GLY  A 346 ( 0.0A)
ASN  A 326 ( 0.6A)
MET  A 345 ( 0.0A)
 1.37A 4koyA-1v0fA:
undetectable		 4koyA-1v0fA:
12.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KUK_A_RBFA201_1
(BLUE-LIGHT
PHOTORECEPTOR)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		5 / 12 VAL C 162
ASN C 137
ASN C  88
LEU C  97
ILE C 101
 VAL  C 162 ( 0.6A)
ASN  C 137 ( 0.6A)
ASN  C  88 ( 0.6A)
LEU  C  97 ( 0.5A)
ILE  C 101 ( 0.6A)
 1.34A 4kukA-5lmxC:
undetectable		 4kukA-5lmxC:
16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L7I_B_SAMB501_0
(S-ADENOSYLMETHIONINE
SYNTHASE)		 5cdn DNA GYRASE SUBUNIT A
(Staphylococcus
aureus) 		4 / 8 ASN A  54
ASP A  40
LEU A 160
ILE A 144
 ASN  A  54 ( 0.6A)
ASP  A  40 ( 0.5A)
LEU  A 160 ( 0.6A)
ILE  A 144 ( 0.4A)
 0.99A 4l7iA-5cdnA:
undetectable		 4l7iA-5cdnA:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L7I_B_SAMB501_0
(S-ADENOSYLMETHIONINE
SYNTHASE)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 8 ASN A 226
ARG A 209
ASP A 238
LEU A 235
 ASN  A 226 ( 0.6A)
ARG  A 209 ( 0.6A)
ASP  A 238 ( 0.5A)
LEU  A 235 ( 0.6A)
 1.07A 4l7iA-5d7wA:
undetectable		 4l7iA-5d7wA:
21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L7I_B_SAMB501_0
(S-ADENOSYLMETHIONINE
SYNTHASE)		 5l5n PLEXIN-A4
(Mus
musculus) 		4 / 8 ASN A 792
LEU A 721
ASN A 796
ILE A 709
 ASN  A 792 ( 0.6A)
LEU  A 721 ( 0.6A)
ASN  A 796 ( 0.6A)
ILE  A 709 ( 0.6A)
 0.89A 4l7iA-5l5nA:
undetectable		 4l7iA-5l5nA:
16.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LMN_A_EUIA503_1
(DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		5 / 12 LEU A  73
ASN A 158
ASP A 171
PHE A 172
GLY A 173
 LEU  A  73 ( 0.6A)
ASN  A 158 ( 0.6A)
ASP  A 171 ( 0.5A)
PHE  A 172 ( 1.3A)
GLY  A 173 ( 0.0A)
 0.72A 4lmnA-5d7aA:
29.6		 4lmnA-5d7aA:
30.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LMN_A_EUIA503_1
(DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		5 / 12 MET A 105
ASN A 158
ASP A 171
PHE A 172
GLY A 173
 MET  A 105 (-0.0A)
ASN  A 158 ( 0.6A)
ASP  A 171 ( 0.5A)
PHE  A 172 ( 1.3A)
GLY  A 173 ( 0.0A)
 1.00A 4lmnA-5d7aA:
29.6		 4lmnA-5d7aA:
30.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LMN_A_EUIA503_2
(DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1)		 4mwt LYSOSOMAL PROTECTIVE
PROTEIN
(Homo
sapiens) 		3 / 3 ASP A 380
VAL A 413
ASN A 376
 ASP  A 380 ( 0.5A)
VAL  A 413 ( 0.6A)
ASN  A 376 ( 0.6A)
 0.76A 4lmnA-4mwtA:
undetectable		 4lmnA-4mwtA:
25.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LNW_A_T3A502_1
(THYROID HORMONE
RECEPTOR ALPHA)		 12as ASPARAGINE
SYNTHETASE
(Escherichia
coli) 		4 / 8 SER A  72
ASP A  46
GLN A 116
ARG A 100
 ASN  A 331 (-2.9A)
ASN  A 331 (-3.4A)
ASN  A 331 ( 3.5A)
AMP  A 332 (-2.9A)
 1.10A 4lnwA-12asA:
0.0		 4lnwA-12asA:
23.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MI4_C_SPMC201_1
(SPERMIDINE
N1-ACETYLTRANSFERASE)		 5k66 NTA1P
(Saccharomyces
cerevisiae) 		4 / 7 TYR A 193
ASN A 119
GLU A 150
GLU A 143
 None
None
None
ASN  A 501 ( 4.8A)
 1.02A 4mi4A-5k66A:
undetectable
4mi4C-5k66A:
undetectable		 4mi4A-5k66A:
15.94
4mi4C-5k66A:
15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MK4_B_CHDB504_0
(FERROCHELATASE,
MITOCHONDRIAL)		 12as ASPARAGINE
SYNTHETASE
(Escherichia
coli) 		3 / 3 LEU A 133
ILE A 291
ARG A 255
 None
None
ASN  A 331 (-3.2A)
 0.59A 4mk4B-12asA:
undetectable		 4mk4B-12asA:
24.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MMC_A_29JA603_1
(TRANSPORTER)		 6h20 -
(-) 		5 / 10 ASP A  99
TYR A 276
SER A 106
GLY A 117
ASP A 250
 None
ASN  A 401 ( 4.9A)
None
None
ASN  A 401 (-2.9A)
 1.42A 4mmcA-6h20A:
undetectable		 4mmcA-6h20A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4N09_B_ADNB401_2
(ADENOSINE KINASE)		 3icc PUTATIVE
3-OXOACYL-(ACYL
CARRIER PROTEIN)
REDUCTASE
(Bacillus
anthracis) 		4 / 5 LEU A  76
LEU A  92
LEU A  80
ASN A  94
 LEU  A  76 ( 0.6A)
LEU  A  92 ( 0.6A)
LEU  A  80 ( 0.5A)
ASN  A  94 ( 0.6A)
 0.95A 4n09B-3iccA:
7.8		 4n09B-3iccA:
23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NC3_A_ERMA1202_2
(CHIMERA PROTEIN OF
HUMAN
5-HYDROXYTRYPTAMINE
RECEPTOR 2B AND E.
COLI SOLUBLE
CYTOCHROME B562)		 4non FERROUS IRON UPTAKE
TRANSPORTER PROTEIN
B
(Streptococcus
thermophilus) 		4 / 6 LEU A  95
ASN A  84
GLN A 100
LEU A 101
 LEU  A  95 ( 0.6A)
ASN  A  84 ( 0.6A)
GLN  A 100 ( 0.6A)
LEU  A 101 ( 0.6A)
 1.27A 4nc3A-4nonA:
undetectable		 4nc3A-4nonA:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKV_A_AERA601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		5 / 12 ALA A  20
ASN A 214
ILE A 216
GLY A 114
ALA A 143
 ALA  A  20 ( 0.0A)
ASN  A 214 ( 0.6A)
ILE  A 216 (-0.7A)
GLY  A 114 ( 0.0A)
ALA  A 143 ( 0.0A)
 1.08A 4nkvA-1omoA:
undetectable		 4nkvA-1omoA:
20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKV_C_AERC601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		5 / 12 ALA A  20
ASN A 214
ILE A 216
GLY A 114
ALA A 143
 ALA  A  20 ( 0.0A)
ASN  A 214 ( 0.6A)
ILE  A 216 (-0.7A)
GLY  A 114 ( 0.0A)
ALA  A 143 ( 0.0A)
 1.09A 4nkvC-1omoA:
undetectable		 4nkvC-1omoA:
20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKV_D_AERD601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		5 / 12 ALA A  20
ASN A 214
ILE A 216
GLY A 114
ALA A 143
 ALA  A  20 ( 0.0A)
ASN  A 214 ( 0.6A)
ILE  A 216 (-0.7A)
GLY  A 114 ( 0.0A)
ALA  A 143 ( 0.0A)
 1.08A 4nkvD-1omoA:
undetectable		 4nkvD-1omoA:
20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O1E_A_C2FA3000_0
(DIHYDROPTEROATE
SYNTHASE DHPS)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		5 / 12 ILE A 666
LEU A 670
GLY A 677
SER A 711
ASN A 735
 ILE  A 666 ( 0.7A)
LEU  A 670 ( 0.5A)
GLY  A 677 ( 0.0A)
SER  A 711 ( 0.0A)
ASN  A 735 ( 0.6A)
 1.20A 4o1eA-4flxA:
undetectable		 4o1eA-4flxA:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O1E_A_C2FA3000_0
(DIHYDROPTEROATE
SYNTHASE DHPS)		 4flx DNA POLYMERASE 1
(Pyrococcus
abyssi) 		5 / 12 ILE A 702
ILE A 666
LEU A 670
GLY A 677
ASN A 735
 ILE  A 702 ( 0.7A)
ILE  A 666 ( 0.7A)
LEU  A 670 ( 0.5A)
GLY  A 677 ( 0.0A)
ASN  A 735 ( 0.6A)
 1.09A 4o1eA-4flxA:
undetectable		 4o1eA-4flxA:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O1E_A_C2FA3000_1
(DIHYDROPTEROATE
SYNTHASE DHPS)		 2qv2 INOSITOL
POLYPHOSPHATE
5-PHOSPHATASE OCRL-1
(Homo
sapiens) 		3 / 3 LYS A 188
ASN A 294
ASP A 184
 LYS  A 188 ( 0.0A)
ASN  A 294 ( 0.6A)
ASP  A 184 ( 0.5A)
 0.79A 4o1eA-2qv2A:
undetectable		 4o1eA-2qv2A:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O7G_A_ASCA303_0
(PROBABLE
TRANSMEMBRANE
ASCORBATE
FERRIREDUCTASE 2)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		4 / 7 PHE A 159
ILE A 142
PHE A 173
ASN A 175
 PHE  A 159 ( 1.3A)
ILE  A 142 ( 0.6A)
PHE  A 173 ( 1.3A)
ASN  A 175 ( 0.6A)
 1.27A 4o7gA-3pu5A:
undetectable
4o7gB-3pu5A:
undetectable		 4o7gA-3pu5A:
21.96
4o7gB-3pu5A:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O7G_B_ASCB304_0
(PROBABLE
TRANSMEMBRANE
ASCORBATE
FERRIREDUCTASE 2)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 6 PHE A 221
ILE A 121
PHE A 260
ASN A 102
 PHE  A 221 ( 1.3A)
ILE  A 121 ( 0.7A)
PHE  A 260 ( 1.3A)
ASN  A 102 ( 0.6A)
 1.47A 4o7gB-4hneA:
undetectable		 4o7gB-4hneA:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OBW_D_SAMD601_1
(2-METHOXY-6-POLYPREN
YL-1,4-BENZOQUINOL
METHYLASE,
MITOCHONDRIAL)		 5lmx DNA-DIRECTED RNA
POLYMERASE I SUBUNIT
RPA34
(Saccharomyces
cerevisiae) 		3 / 3 ASN N 106
ASP N  94
ASP N 134
 ASN  N 106 ( 0.6A)
ASP  N  94 ( 0.5A)
ASP  N 134 ( 0.5A)
 0.84A 4obwD-5lmxN:
undetectable		 4obwD-5lmxN:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OBW_D_SAMD601_1
(2-METHOXY-6-POLYPREN
YL-1,4-BENZOQUINOL
METHYLASE,
MITOCHONDRIAL)		 5lmx DNA-DIRECTED RNA
POLYMERASES I AND
III SUBUNIT
RPAC1,DNA-DIRECTED
RNA POLYMERASES I
AND III SUBUNIT
RPAC1
(Saccharomyces
cerevisiae) 		3 / 3 ASN C  53
ASP C  55
ASP C 269
 ASN  C  53 ( 0.6A)
ASP  C  55 ( 0.5A)
ASP  C 269 ( 0.5A)
 0.88A 4obwD-5lmxC:
undetectable		 4obwD-5lmxC:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGR_A_ADNA401_1
(CYCLIN-DEPENDENT
KINASE 9)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		6 / 8 GLY A  34
VAL A  39
ALA A  52
ASN A 158
LEU A 160
ASP A 171
 GLY  A  34 ( 0.0A)
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
ASN  A 158 ( 0.6A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
 0.58A 4ogrA-5d7aA:
26.3		 4ogrA-5d7aA:
25.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGR_I_ADNI401_1
(CYCLIN-DEPENDENT
KINASE 9)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		6 / 9 GLY A  34
VAL A  39
ALA A  52
ASN A 158
LEU A 160
ASP A 171
 GLY  A  34 ( 0.0A)
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
ASN  A 158 ( 0.6A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
 0.53A 4ogrI-5d7aA:
26.7		 4ogrI-5d7aA:
25.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OK1_A_198A1001_2
(ANDROGEN RECEPTOR)		 2j5b TYROSYL-TRNA
SYNTHETASE
(Acanthamoeba
polyphaga
mimivirus) 		4 / 8 LEU A 182
ASN A 190
MET A 127
ILE A 204
 LEU  A 182 (-0.6A)
ASN  A 190 ( 0.6A)
MET  A 127 ( 0.0A)
ILE  A 204 ( 0.7A)
 0.87A 4ok1A-2j5bA:
undetectable		 4ok1A-2j5bA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OLM_A_198A1001_2
(ANDROGEN RECEPTOR)		 4ikn AP-3 COMPLEX SUBUNIT
MU-1
(Rattus
norvegicus) 		4 / 6 ASN A 372
ILE A 191
ILE A 190
VAL A 198
 ASN  A 372 ( 0.6A)
ILE  A 191 ( 0.7A)
ILE  A 190 ( 0.7A)
VAL  A 198 ( 0.6A)
 0.89A 4olmA-4iknA:
undetectable		 4olmA-4iknA:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OU1_A_BEZA302_0
(RETRO-ALDOLASE,
DESIGN RA114)		 4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB
(Caldanaerobacter
subterraneus) 		4 / 8 ILE A  63
ILE A  61
ASN A  22
ALA A  23
 ILE  A  63 ( 0.7A)
ILE  A  61 ( 0.4A)
ASN  A  22 ( 0.6A)
ALA  A  23 ( 0.0A)
 0.96A 4ou1A-4egsA:
undetectable		 4ou1A-4egsA:
24.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P6X_I_HCYI900_1
(GLUCOCORTICOID
RECEPTOR)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		5 / 12 LEU A 676
ASN A 683
LEU A 373
ILE A 710
PHE A 715
 LEU  A 676 ( 0.6A)
ASN  A 683 ( 0.6A)
LEU  A 373 ( 0.6A)
ILE  A 710 ( 0.7A)
PHE  A 715 ( 1.3A)
 1.47A 4p6xI-4zkeA:
undetectable		 4p6xI-4zkeA:
21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PB1_A_RBVA501_1
(NUPC FAMILY PROTEIN)		 3ghg FIBRINOGEN GAMMA
CHAIN
(Homo
sapiens) 		5 / 12 GLY C 200
GLU C 225
ASN C 365
SER C 378
ILE C 367
 GLY  C 200 ( 0.0A)
GLU  C 225 ( 0.5A)
ASN  C 365 ( 0.6A)
SER  C 378 ( 0.0A)
ILE  C 367 ( 0.5A)
 1.26A 4pb1A-3ghgC:
undetectable		 4pb1A-3ghgC:
19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PGF_B_ADNB502_2
(ADENOSYLHOMOCYSTEINA
SE)		 1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii) 		4 / 5 THR A 284
THR A 305
THR A   7
ASN A 328
 THR  A 284 ( 0.8A)
THR  A 305 ( 0.8A)
THR  A   7 ( 0.8A)
ASN  A 328 ( 0.6A)
 1.35A 4pgfB-1wqaA:
2.4		 4pgfB-1wqaA:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4POO_A_SAMA301_0
(PUTATIVE RNA
METHYLASE)		 5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE
(Bacillus
subtilis) 		5 / 12 GLY A 225
ASN A 226
ASP A  52
ILE A 184
SER A 183
 GLY  A 225 ( 0.0A)
ASN  A 226 ( 0.6A)
ASP  A  52 ( 0.6A)
ILE  A 184 ( 0.4A)
SER  A 183 ( 0.0A)
 1.28A 4pooA-5ep8A:
undetectable		 4pooA-5ep8A:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4POO_B_SAMB301_0
(PUTATIVE RNA
METHYLASE)		 5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE
(Bacillus
subtilis) 		5 / 12 GLY A 225
ASN A 226
ASP A  52
ILE A 184
SER A 183
 GLY  A 225 ( 0.0A)
ASN  A 226 ( 0.6A)
ASP  A  52 ( 0.6A)
ILE  A 184 ( 0.4A)
SER  A 183 ( 0.0A)
 1.32A 4pooB-5ep8A:
undetectable		 4pooB-5ep8A:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QCK_A_ASDA404_1
(3-KETOSTEROID-9-ALPH
A-MONOOXYGENASE
OXYGENASE SUBUNIT)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		5 / 12 ASN A 136
VAL A 135
LEU A 250
ALA A  57
GLY A 228
 ASN  A 136 ( 0.6A)
VAL  A 135 ( 0.6A)
LEU  A 250 ( 0.6A)
ALA  A  57 ( 0.0A)
GLY  A 228 ( 0.0A)
 1.22A 4qckA-3r6yA:
undetectable		 4qckA-3r6yA:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QD3_A_5AEA201_1
(PEPTIDYL-TRNA
HYDROLASE)		 5x5l ADER
(Acinetobacter
baumannii) 		5 / 9 LEU A 192
GLY A 234
ASN A 229
VAL A 207
VAL A 211
 LEU  A 192 ( 0.6A)
GLY  A 234 ( 0.0A)
ASN  A 229 ( 0.6A)
VAL  A 207 ( 0.6A)
VAL  A 211 ( 0.6A)
 0.98A 4qd3A-5x5lA:
undetectable		 4qd3A-5x5lA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RET_A_DGXA1107_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		4 / 4 ASN A 141
VAL A   4
THR A 135
ILE A 162
 ASN  A 141 ( 0.6A)
VAL  A   4 ( 0.6A)
THR  A 135 ( 0.8A)
ILE  A 162 ( 0.7A)
 1.27A 4retA-2vbfA:
3.2		 4retA-2vbfA:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RET_C_DGXC2005_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		4 / 4 ASN A 141
VAL A   4
THR A 135
ILE A 162
 ASN  A 141 ( 0.6A)
VAL  A   4 ( 0.6A)
THR  A 135 ( 0.8A)
ILE  A 162 ( 0.7A)
 1.27A 4retC-2vbfA:
2.4		 4retC-2vbfA:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RTR_A_SAMA301_0
(DNA ADENINE
METHYLASE)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		5 / 11 GLY A 396
PHE A 442
ILE A 174
ASN A 177
TYR A 127
 GLY  A 396 ( 0.0A)
PHE  A 442 ( 1.3A)
ILE  A 174 ( 0.6A)
ASN  A 177 (-0.6A)
TYR  A 127 ( 1.3A)
 1.22A 4rtrA-3gnrA:
undetectable		 4rtrA-3gnrA:
19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4U15_A_0HKA2001_2
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M3,LYSOZYME,MUSCARIN
IC ACETYLCHOLINE
RECEPTOR M3)		 2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1
(Homo
sapiens) 		3 / 3 ASN A 111
PHE A 116
TYR A 144
 ASN  A 111 ( 0.6A)
PHE  A 116 ( 1.3A)
TYR  A 144 ( 1.3A)
 0.58A 4u15A-2b92A:
undetectable		 4u15A-2b92A:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4U15_A_0HKA2001_2
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M3,LYSOZYME,MUSCARIN
IC ACETYLCHOLINE
RECEPTOR M3)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		3 / 3 ASN A 177
PHE A 442
TYR A  87
 ASN  A 177 (-0.6A)
PHE  A 442 ( 1.3A)
TYR  A  87 ( 1.3A)
 0.68A 4u15A-3gnrA:
undetectable		 4u15A-3gnrA:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WS0_A_URFA301_1
(URACIL-DNA
GLYCOSYLASE)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 7 GLY A 354
GLN A 355
SER A 351
ASN A 359
 GLY  A 354 ( 0.0A)
GLN  A 355 ( 0.6A)
SER  A 351 ( 0.0A)
ASN  A 359 ( 0.6A)
 0.95A 4ws0A-3r6yA:
undetectable		 4ws0A-3r6yA:
19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WS1_A_URFA301_1
(URACIL-DNA
GLYCOSYLASE)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		4 / 8 GLY A 354
GLN A 355
SER A 351
ASN A 359
 GLY  A 354 ( 0.0A)
GLN  A 355 ( 0.6A)
SER  A 351 ( 0.0A)
ASN  A 359 ( 0.6A)
 0.94A 4ws1A-3r6yA:
undetectable		 4ws1A-3r6yA:
19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X20_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5wo6 TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 6
(Rattus
norvegicus) 		5 / 12 LEU A 136
ALA A 135
ASN A  92
ALA A  86
ALA A 120
 LEU  A 136 ( 0.6A)
ALA  A 135 ( 0.0A)
ASN  A  92 ( 0.6A)
ALA  A  86 ( 0.0A)
ALA  A 120 ( 0.0A)
 1.00A 4x20B-5wo6A:
undetectable		 4x20B-5wo6A:
20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X3U_B_SVRB102_1
(CHROMOBOX PROTEIN
HOMOLOG 7)		 5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE
(Homo
sapiens) 		3 / 3 LYS A 186
ARG A 152
VAL A 174
 ASN  A 186 ( 0.0A)
ARG  A 152 ( 0.6A)
VAL  A 174 ( 0.6A)
 0.88A 4x3uA-5d7aA:
undetectable
4x3uB-5d7aA:
undetectable		 4x3uA-5d7aA:
10.97
4x3uB-5d7aA:
10.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YV5_A_SVRA205_2
(BASIC PHOSPHOLIPASE
A2 HOMOLOG 2)		 3s6f HYPOTHETICAL
ACETYLTRANSFERASE
(Deinococcus
radiodurans) 		4 / 6 LEU A  66
ASN A  64
PRO A  76
ARG A 134
 LEU  A  66 ( 0.5A)
ASN  A  64 ( 0.6A)
PRO  A  76 ( 1.1A)
ARG  A 134 ( 0.6A)
 1.27A 4yv5B-3s6fA:
undetectable		 4yv5B-3s6fA:
18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YV5_B_SVRB207_1
(BASIC PHOSPHOLIPASE
A2 HOMOLOG 2)		 3s6f HYPOTHETICAL
ACETYLTRANSFERASE
(Deinococcus
radiodurans) 		4 / 6 LEU A  66
ASN A  64
PRO A  76
ARG A 134
 LEU  A  66 ( 0.5A)
ASN  A  64 ( 0.6A)
PRO  A  76 ( 1.1A)
ARG  A 134 ( 0.6A)
 1.27A 4yv5A-3s6fA:
undetectable		 4yv5A-3s6fA:
18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZBQ_A_DIFA602_1
(SERUM ALBUMIN)		 2hk0 D-PSICOSE
3-EPIMERASE
(Agrobacterium
tumefaciens) 		4 / 8 ASP A 275
ASN A 278
ALA A 279
GLU A 212
 ASP  A 275 ( 0.6A)
ASN  A 278 ( 0.6A)
ALA  A 279 ( 0.0A)
GLU  A 212 ( 0.6A)
 0.90A 4zbqA-2hk0A:
undetectable		 4zbqA-2hk0A:
19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		 5w6l RTX
REPEAT-CONTAINING
CYTOTOXIN
(Vibrio
vulnificus) 		4 / 7 MET A3674
GLY A3705
ASN A3704
HIS A3707
 ALA  A3699 ( 3.5A)
GLY  A3705 ( 0.0A)
ASN  A3704 ( 0.6A)
HIS  A3707 ( 1.0A)
 1.22A 5a5zC-5w6lA:
undetectable		 5a5zC-5w6lA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BPH_A_ACTA403_0
(D-ALANINE--D-ALANINE
LIGASE)		 12as ASPARAGINE
SYNTHETASE
(Escherichia
coli) 		4 / 6 TYR A 218
GLY A  50
SER A  49
LEU A  48
 ASN  A 331 (-4.3A)
None
None
None
 1.19A 5bphA-12asA:
undetectable		 5bphA-12asA:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BPH_C_ACTC403_0
(D-ALANINE--D-ALANINE
LIGASE)		 12as ASPARAGINE
SYNTHETASE
(Escherichia
coli) 		4 / 4 TYR A 218
GLY A  50
SER A  49
LEU A  48
 ASN  A 331 (-4.3A)
None
None
None
 1.20A 5bphC-12asA:
undetectable		 5bphC-12asA:
24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CCM_A_SAMA504_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SMYD3)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 GLY A 222
ASN A 223
TYR A 202
HIS A 248
TYR A 240
 GLY  A 222 ( 0.0A)
ASN  A 223 ( 0.6A)
TYR  A 202 ( 1.3A)
HIS  A 248 ( 1.0A)
TYR  A 240 ( 1.3A)
 1.31A 5ccmA-5nqfA:
undetectable		 5ccmA-5nqfA:
20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DSG_B_0HKB1201_2
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR
M4,ENDOLYSIN,ENDOLYS
IN,MUSCARINIC
ACETYLCHOLINE
RECEPTOR M4)		 5l5n PLEXIN-A4
(Mus
musculus) 		3 / 3 ASP A 368
ASN A 363
PHE A 357
 ASP  A 368 ( 0.5A)
ASN  A 363 ( 0.6A)
PHE  A 357 ( 1.3A)
 0.66A 5dsgB-5l5nA:
undetectable		 5dsgB-5l5nA:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EUM_B_ACTB603_0
(LIPID A EXPORT
ATP-BINDING/PERMEASE
PROTEIN MSBA)		 5ec3 4-HYDROXYPHENYLPYRUV
ATE DIOXYGENASE
(Homo
sapiens) 		4 / 4 ALA A 316
ASN A 313
ARG A 279
ILE A 275
 ALA  A 316 ( 0.0A)
ASN  A 313 ( 0.6A)
ARG  A 279 ( 0.6A)
ILE  A 275 ( 0.7A)
 1.16A 5eumB-5ec3A:
undetectable		 5eumB-5ec3A:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FCT_B_C2FB402_1
(THYMIDYLATE SYNTHASE)		 1ng0 COAT PROTEIN
(Cocksfoot
mottle
virus) 		3 / 3 ASN A 158
ASP A 164
GLY A 177
 ASN  A 158 ( 0.6A)
ASP  A 164 ( 0.6A)
GLY  A 177 ( 0.0A)
 0.67A 5fctB-1ng0A:
undetectable		 5fctB-1ng0A:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FHR_A_SAMA303_0
(CATECHOL
O-METHYLTRANSFERASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 ASN A 293
VAL A 294
MET A 224
ASN A 225
HIS A 220
 ASN  A 293 ( 0.6A)
VAL  A 294 ( 0.6A)
MET  A 224 ( 0.0A)
ASN  A 225 ( 0.6A)
HIS  A 220 ( 1.0A)
 1.48A 5fhrA-5nqfA:
undetectable		 5fhrA-5nqfA:
18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5GSN_A_MMZA503_1
(FLAVIN-CONTAINING
MONOOXYGENASE)		 5l5n PLEXIN-A4
(Mus
musculus) 		3 / 3 ASN A 725
SER A 756
SER A 757
 ASN  A 725 ( 0.6A)
SER  A 756 ( 0.0A)
SER  A 757 ( 0.0A)
 0.63A 5gsnA-5l5nA:
undetectable		 5gsnA-5l5nA:
17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5GWX_A_SAMA301_1
(GLYCINE SARCOSINE
N-METHYLTRANSFERASE)		 3r6y ASPARTASE
(Bacillus
sp.
YM55-1) 		3 / 3 ARG A 210
ASN A 287
ASP A 294
 ARG  A 210 ( 0.6A)
ASN  A 287 ( 0.6A)
ASP  A 294 ( 0.6A)
 0.78A 5gwxA-3r6yA:
undetectable		 5gwxA-3r6yA:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_C_P06C801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9) 		4 / 7 ILE A 348
VAL A 438
ASN A 416
PHE A  83
 ILE  A 348 ( 0.4A)
VAL  A 438 ( 0.6A)
ASN  A 416 ( 0.6A)
PHE  A  83 ( 1.3A)
 0.96A 5hieC-4kqnA:
undetectable		 5hieC-4kqnA:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HWK_A_BEZA301_0
(GLUTATHIONE-SPECIFIC
GAMMA-GLUTAMYLCYCLOT
RANSFERASE)		 2him L-ASPARAGINASE 1
(Escherichia
coli) 		5 / 10 GLY A  90
GLY A 116
SER A 117
LEU A  31
TYR A  10
 ASN  A6001 ( 3.1A)
None
None
None
None
 1.23A 5hwkA-2himA:
undetectable		 5hwkA-2himA:
20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HWK_B_BEZB301_0
(GLUTATHIONE-SPECIFIC
GAMMA-GLUTAMYLCYCLOT
RANSFERASE)		 2him L-ASPARAGINASE 1
(Escherichia
coli) 		5 / 10 GLY A  90
GLY A 116
SER A 117
LEU A  31
TYR A  10
 ASN  A6001 ( 3.1A)
None
None
None
None
 1.22A 5hwkB-2himA:
undetectable		 5hwkB-2himA:
20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I1O_F_DVAF9_0
(D-VILLIN HEADPIECE
SUBDOMAIN
VILLIN-1)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		3 / 3 ALA A 558
ASN A 561
LEU A 562
 ALA  A 558 ( 0.0A)
ASN  A 561 ( 0.6A)
LEU  A 562 ( 0.6A)
 0.30A 5i1oC-5c05A:
undetectable		 5i1oC-5c05A:
8.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I1P_F_DVAF9_0
(D-VILLIN HEADPIECE
SUBDOMAIN
VILLIN-1)		 5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE
(Thymus
vulgaris) 		3 / 3 ALA A 558
ASN A 561
LEU A 562
 ALA  A 558 ( 0.0A)
ASN  A 561 ( 0.6A)
LEU  A 562 ( 0.6A)
 0.36A 5i1pA-5c05A:
undetectable		 5i1pA-5c05A:
10.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J4N_A_AG2A501_1
(ARGININE/AGMATINE
ANTIPORTER)		 5d7w SERRALYSIN
(Serratia
marcescens) 		4 / 6 SER A 309
GLY A 342
ASN A 343
ILE A 303
 SER  A 309 ( 0.0A)
GLY  A 342 ( 0.0A)
ASN  A 343 (-0.6A)
ILE  A 303 ( 0.7A)
 0.86A 5j4nA-5d7wA:
undetectable		 5j4nA-5d7wA:
23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J4N_B_AG2B501_1
(ARGININE/AGMATINE
ANTIPORTER)		 2qc5 STREPTOGRAMIN B
LACTONASE
(Staphylococcus
cohnii) 		4 / 6 ILE A 272
GLY A 191
ASN A 192
ILE A 230
 ILE  A 272 ( 0.7A)
GLY  A 191 ( 0.0A)
ASN  A 192 ( 0.6A)
ILE  A 230 ( 0.6A)
 0.96A 5j4nB-2qc5A:
undetectable		 5j4nB-2qc5A:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JGL_B_SAMB301_1
(UBIE/COQ5 FAMILY
METHYLTRANSFERASE,
PUTATIVE)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		3 / 3 ASP A 136
ASN A  47
PHE A  92
 ASP  A 136 ( 0.6A)
ASN  A  47 ( 0.6A)
PHE  A  92 ( 1.3A)
 0.92A 5jglB-3pu5A:
undetectable		 5jglB-3pu5A:
24.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5K4P_A_SORA611_0
(PROBABLE
PHOSPHATIDYLETHANOLA
MINE TRANSFERASE
MCR-1)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		4 / 6 THR A 282
SER A 281
GLY A 279
ASN A 315
 THR  A 282 (-0.8A)
SER  A 281 ( 0.0A)
GLY  A 279 (-0.0A)
ASN  A 315 (-0.6A)
 0.86A 5k4pA-4zkeA:
undetectable		 5k4pA-4zkeA:
19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KBW_A_RBFA201_1
(RIBOFLAVIN
TRANSPORTER RIBU)		 3gnr OS03G0212800 PROTEIN
(Oryza
sativa) 		5 / 12 GLY A 373
MET A 374
ASN A 426
LEU A 427
ASN A 395
 GLY  A 373 ( 0.0A)
MET  A 374 ( 0.0A)
ASN  A 426 ( 0.6A)
LEU  A 427 ( 0.5A)
ASN  A 395 ( 0.6A)
 1.32A 5kbwA-3gnrA:
1.9		 5kbwA-3gnrA:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L1F_C_6ZPC902_1
(GLUTAMATE RECEPTOR 2)		 4zke SUPERKILLER PROTEIN
7
(Saccharomyces
cerevisiae) 		4 / 7 ASP A 376
PRO A 377
TYR A 380
ASN A 728
 ASP  A 376 ( 0.6A)
PRO  A 377 ( 1.1A)
TYR  A 380 ( 1.3A)
ASN  A 728 ( 0.6A)
 1.02A 5l1fC-4zkeA:
4.6		 5l1fC-4zkeA:
20.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L2T_A_6ZZA900_2
(CYCLIN-DEPENDENT
KINASE 6)		 1it2 HEMOGLOBIN
(Eptatretus
burgeri) 		3 / 3 LYS A  78
GLN A  89
ASN A  88
 LYS  A  78 (-0.0A)
GLN  A  89 ( 0.6A)
ASN  A  88 ( 0.6A)
 0.99A 5l2tA-1it2A:
undetectable		 5l2tA-1it2A:
17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVS_A_ADNA401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)		 1vho ENDOGLUCANASE
(Thermotoga
maritima) 		4 / 7 GLY A  17
GLU A  68
ALA A 168
ASN A  24
 GLY  A  17 ( 0.0A)
GLU  A  68 ( 0.6A)
ALA  A 168 ( 0.0A)
ASN  A  24 ( 0.6A)
 0.97A 5mvsA-1vhoA:
undetectable		 5mvsA-1vhoA:
24.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVS_B_ADNB401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)		 1vho ENDOGLUCANASE
(Thermotoga
maritima) 		4 / 8 GLY A  17
GLU A  68
ALA A 168
ASN A  24
 GLY  A  17 ( 0.0A)
GLU  A  68 ( 0.6A)
ALA  A 168 ( 0.0A)
ASN  A  24 ( 0.6A)
 0.96A 5mvsB-1vhoA:
undetectable		 5mvsB-1vhoA:
24.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N4T_B_BEZB306_0
(BETA-LACTAMASE VIM-2)		 4w65 GLYCOSYL HYDROLASE
FAMILY PROTEIN
(Mycolicibacteriu
m
fortuitum) 		3 / 3 HIS A 193
ASN A 194
ALA A 196
 HIS  A 193 ( 1.0A)
ASN  A 194 ( 0.6A)
ALA  A 196 ( 0.0A)
 0.78A 5n4tB-4w65A:
undetectable		 5n4tB-4w65A:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NM5_B_LOCB502_1
(TUBULIN ALPHA-1B
CHAIN
TUBULIN BETA-2B
CHAIN)		 2pnn TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 1
(Rattus
norvegicus) 		4 / 4 ASN A 125
SER A 116
ALA A 120
VAL A 121
 ASN  A 125 ( 0.6A)
SER  A 116 ( 0.0A)
ALA  A 120 ( 0.0A)
VAL  A 121 ( 0.6A)
 1.39A 5nm5A-2pnnA:
undetectable		 5nm5A-2pnnA:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NVP_A_ACAA18_1
(ENVELOPE
GLYCOPROTEIN,GP41)		 3r64 NAD DEPENDENT
BENZALDEHYDE
DEHYDROGENASE
(Corynebacterium
glutamicum) 		5 / 12 SER A 327
ASN A  34
GLU A  99
GLU A  94
LEU A  96
 SER  A 327 ( 0.0A)
ASN  A  34 ( 0.6A)
GLU  A  99 ( 0.6A)
GLU  A  94 ( 0.6A)
LEU  A  96 ( 0.6A)
 1.11A 5nvpA-3r64A:
0.0		 5nvpA-3r64A:
5.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NZY_A_CE3A1102_1
(DNA CROSS-LINK
REPAIR 1A PROTEIN)		 5m2m LLAMA NANOBODY VHH3
(Lama
glama) 		4 / 7 ASN D  62
ARG D  55
ILE D  56
GLY D  40
 ASN  D  62 ( 0.6A)
ARG  D  55 ( 0.6A)
ILE  D  56 ( 0.6A)
GLY  D  40 ( 0.0A)
 0.92A 5nzyA-5m2mD:
undetectable		 5nzyA-5m2mD:
16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UHB_C_RFPC1201_1
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA)		 1omo ALANINE
DEHYDROGENASE
(Archaeoglobus
fulgidus) 		5 / 12 LEU A 293
GLN A 296
SER A 290
ASN A 214
ILE A 216
 LEU  A 293 ( 0.6A)
GLN  A 296 ( 0.6A)
SER  A 290 (-0.0A)
ASN  A 214 ( 0.6A)
ILE  A 216 (-0.7A)
 1.21A 5uhbC-1omoA:
2.1		 5uhbC-1omoA:
15.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UMD_A_YMZA3801_1
(60S RIBOSOMAL
PROTEIN L28
28S RIBOSOMAL RNA
60S RIBOSOMAL
PROTEIN L4)		 4ki5 MURINE MONOCLONAL
G99 FAB HEAVY CHAIN
(Mus
musculus) 		4 / 6 ASN E  77
ALA E  24
PRO E  53
TYR E  27
 ASN  E  77 ( 0.6A)
ALA  E  24 ( 0.0A)
PRO  E  53 ( 1.1A)
TYR  E  27 ( 1.3A)
 1.05A 5umd2-4ki5E:
undetectable
5umdF-4ki5E:
undetectable		 5umd2-4ki5E:
17.39
5umdF-4ki5E:
16.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VLM_A_CVIA301_1
(REGULATORY PROTEIN
TETR)		 12as ASPARAGINE
SYNTHETASE
(Escherichia
coli) 		4 / 8 GLY A 234
ARG A 255
GLN A 289
TYR A 218
 None
ASN  A 331 (-3.2A)
None
ASN  A 331 (-4.3A)
 1.01A 5vlmA-12asA:
undetectable		 5vlmA-12asA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X66_A_MTXA402_1
(THYMIDYLATE SYNTHASE)		 2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE
(Lactococcus
lactis) 		5 / 12 LEU A  69
GLY A  22
PHE A  21
ASN A  46
ASP A  40
 LEU  A  69 ( 0.5A)
GLY  A  22 ( 0.0A)
PHE  A  21 ( 1.3A)
ASN  A  46 ( 0.6A)
ASP  A  40 ( 0.6A)
 1.13A 5x66A-2vbfA:
undetectable
5x66B-2vbfA:
undetectable		 5x66A-2vbfA:
19.89
5x66B-2vbfA:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDH_A_DAHA60_1
(PUTATIVE CYTOCHROME
C)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 6 ASN A 206
VAL A 342
LEU A 315
GLN A 293
 ASN  A 206 ( 0.6A)
VAL  A 342 ( 0.5A)
LEU  A 315 ( 0.5A)
GLN  A 293 ( 0.6A)
 1.07A 5xdhA-4hneA:
undetectable
5xdhC-4hneA:
undetectable		 5xdhA-4hneA:
11.94
5xdhC-4hneA:
11.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDH_C_DAHC60_1
(PUTATIVE CYTOCHROME
C)		 4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA
(Homo
sapiens) 		4 / 6 GLN A 293
ASN A 206
VAL A 342
LEU A 315
 GLN  A 293 ( 0.6A)
ASN  A 206 ( 0.6A)
VAL  A 342 ( 0.5A)
LEU  A 315 ( 0.5A)
 1.08A 5xdhA-4hneA:
undetectable
5xdhC-4hneA:
undetectable		 5xdhA-4hneA:
11.94
5xdhC-4hneA:
11.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDH_D_DAHD60_1
(PUTATIVE CYTOCHROME
C)		 5l5n PLEXIN-A4
(Mus
musculus) 		4 / 5 HIS A 630
ASN A 654
VAL A 619
LEU A 597
 HIS  A 630 ( 1.0A)
ASN  A 654 ( 0.6A)
VAL  A 619 ( 0.6A)
LEU  A 597 ( 0.5A)
 1.38A 5xdhD-5l5nA:
undetectable		 5xdhD-5l5nA:
5.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XXD_A_SAMA501_0
(SMYD3
METHYLTRANSFERASE)		 5nqf APICAL MEMBRANE
ANTIGEN 1
(Plasmodium
falciparum) 		5 / 12 GLY A 222
ASN A 223
TYR A 202
HIS A 248
TYR A 240
 GLY  A 222 ( 0.0A)
ASN  A 223 ( 0.6A)
TYR  A 202 ( 1.3A)
HIS  A 248 ( 1.0A)
TYR  A 240 ( 1.3A)
 1.32A 5xxdA-5nqfA:
undetectable		 5xxdA-5nqfA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_B_CHDB401_0
(BILE SALT HYDROLASE)		 4jbe GAMMA-GLUTAMYL
PHOSPHATE REDUCTASE
(Saccharomonospor
a
viridis) 		5 / 10 ILE A 166
LEU A 162
ASN A  53
LEU A 155
ALA A 154
 ILE  A 166 ( 0.7A)
LEU  A 162 ( 0.6A)
ASN  A  53 ( 0.6A)
LEU  A 155 ( 0.5A)
ALA  A 154 ( 0.0A)
 1.06A 5y7pB-4jbeA:
undetectable		 5y7pB-4jbeA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_D_CHDD401_0
(BILE SALT HYDROLASE)		 4jbe GAMMA-GLUTAMYL
PHOSPHATE REDUCTASE
(Saccharomonospor
a
viridis) 		5 / 10 ILE A 166
LEU A 162
ASN A  53
LEU A 155
ALA A 154
 ILE  A 166 ( 0.7A)
LEU  A 162 ( 0.6A)
ASN  A  53 ( 0.6A)
LEU  A 155 ( 0.5A)
ALA  A 154 ( 0.0A)
 1.03A 5y7pD-4jbeA:
undetectable		 5y7pD-4jbeA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y7P_H_CHDH401_0
(BILE SALT HYDROLASE)		 4jbe GAMMA-GLUTAMYL
PHOSPHATE REDUCTASE
(Saccharomonospor
a
viridis) 		5 / 10 ILE A 166
LEU A 162
ASN A  53
LEU A 155
ALA A 154
 ILE  A 166 ( 0.7A)
LEU  A 162 ( 0.6A)
ASN  A  53 ( 0.6A)
LEU  A 155 ( 0.5A)
ALA  A 154 ( 0.0A)
 1.00A 5y7pH-4jbeA:
undetectable		 5y7pH-4jbeA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YW0_A_ACTA412_0
(UNCHARACTERIZED
PROTEIN KDOO)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		3 / 3 LYS A  33
ASN A  31
SER A  24
 LYS  A  33 ( 0.0A)
ASN  A  31 ( 0.6A)
SER  A  24 ( 0.0A)
 1.17A 5yw0A-2nvvA:
undetectable		 5yw0A-2nvvA:
21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YW0_A_ACTA412_0
(UNCHARACTERIZED
PROTEIN KDOO)		 5w0a GLUCANASE
(Trichoderma
harzianum) 		3 / 3 LYS A   1
ASN A 160
SER A 168
 GLN  A   1 ( 0.0A)
ASN  A 160 ( 0.6A)
SER  A 168 ( 0.0A)
 1.13A 5yw0A-5w0aA:
undetectable		 5yw0A-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z0F_B_DAHB98_0
(MELC
TYROSINASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 1.04A 5z0fA-3ulkA:
undetectable
5z0fB-3ulkA:
undetectable		 5z0fA-3ulkA:
10.71
5z0fB-3ulkA:
10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z0G_B_DAHB98_0
(MELC
TYROSINASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 0.97A 5z0gA-3ulkA:
undetectable
5z0gB-3ulkA:
undetectable		 5z0gA-3ulkA:
10.71
5z0gB-3ulkA:
10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z0H_B_DAHB98_0
(MELC
TYROSINASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 0.95A 5z0hA-3ulkA:
undetectable
5z0hB-3ulkA:
undetectable		 5z0hA-3ulkA:
10.71
5z0hB-3ulkA:
10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z0I_B_DAHB98_0
(MELC
TYROSINASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 0.97A 5z0iA-3ulkA:
undetectable
5z0iB-3ulkA:
undetectable		 5z0iA-3ulkA:
10.71
5z0iB-3ulkA:
10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z0J_B_DAHB98_0
(MELC
TYROSINASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 0.97A 5z0jA-3ulkA:
undetectable
5z0jB-3ulkA:
undetectable		 5z0jA-3ulkA:
10.71
5z0jB-3ulkA:
10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z0K_B_DAHB98_0
(MELC
TYROSINASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 0.97A 5z0kA-3ulkA:
undetectable
5z0kB-3ulkA:
undetectable		 5z0kA-3ulkA:
10.71
5z0kB-3ulkA:
10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z0L_B_DAHB98_0
(MELC
TYROSINASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 0.96A 5z0lA-3ulkA:
undetectable
5z0lB-3ulkA:
undetectable		 5z0lA-3ulkA:
10.71
5z0lB-3ulkA:
10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z0M_B_DAHB98_0
(MELC
TYROSINASE)		 3ulk KETOL-ACID
REDUCTOISOMERASE
(Escherichia
coli) 		5 / 11 ASN A 181
HIS A 178
VAL A 177
ASP A 182
PRO A 183
 ASN  A 181 ( 0.6A)
HIS  A 178 ( 1.0A)
VAL  A 177 ( 0.6A)
ASP  A 182 ( 0.6A)
PRO  A 183 ( 1.1A)
 0.97A 5z0mA-3ulkA:
undetectable
5z0mB-3ulkA:
undetectable		 5z0mA-3ulkA:
10.71
5z0mB-3ulkA:
10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZW4_A_SAMA302_0
(PUTATIVE
O-METHYLTRANSFERASE
YRRM)		 6c0w HISTONE H3-LIKE
CENTROMERIC PROTEIN
A
HISTONE H4
(Homo
sapiens;
Homo
sapiens) 		5 / 12 TYR B  88
ASN B  64
ALA A  71
ALA A  98
PHE A  67
 TYR  B  88 ( 1.3A)
ASN  B  64 ( 0.6A)
ALA  A  71 ( 0.0A)
ALA  A  98 ( 0.0A)
PHE  A  67 ( 1.3A)
 1.05A 5zw4A-6c0wB:
undetectable		 5zw4A-6c0wB:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A5Y_D_9CRD501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)		 2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN
(Porphyromonas
gingivalis) 		3 / 3 ASN A  51
VAL A  15
HIS A  16
 ASN  A  51 ( 0.6A)
VAL  A  15 ( 0.6A)
HIS  A  16 ( 1.0A)
 0.83A 6a5yD-2nvvA:
undetectable		 6a5yD-2nvvA:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A7P_B_9SCB601_1
(SERUM ALBUMIN)		 5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4
(Homo
sapiens) 		4 / 6 ASN A  26
PHE A  31
LEU A 409
SER A 405
 ASN  A  26 ( 0.6A)
PHE  A  31 ( 1.3A)
LEU  A 409 ( 0.5A)
SER  A 405 ( 0.0A)
 1.25A 6a7pB-5nksA:
undetectable		 6a7pB-5nksA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B3A_A_SAMA701_0
(APRA
METHYLTRANSFERASE 1)		 5w0a GLUCANASE
(Trichoderma
harzianum) 		5 / 12 GLY A 163
ASN A 153
ALA A 156
ASP A 115
LEU A 112
 GLY  A 163 ( 0.0A)
ASN  A 153 ( 0.6A)
ALA  A 156 (-0.0A)
ASP  A 115 ( 0.5A)
LEU  A 112 ( 0.6A)
 0.96A 6b3aA-5w0aA:
undetectable		 6b3aA-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B3B_A_SAMA701_0
(APRA
METHYLTRANSFERASE 1)		 5w0a GLUCANASE
(Trichoderma
harzianum) 		5 / 12 GLY A 163
ASN A 153
ALA A 156
ASP A 115
LEU A 112
 GLY  A 163 ( 0.0A)
ASN  A 153 ( 0.6A)
ALA  A 156 (-0.0A)
ASP  A 115 ( 0.5A)
LEU  A 112 ( 0.6A)
 0.95A 6b3bA-5w0aA:
undetectable		 6b3bA-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BQG_A_ERMA1201_1
(5-HYDROXYTRYPTAMINE
RECEPTOR 2C,SOLUBLE
CYTOCHROME B562)		 5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE
(Bacillus
subtilis) 		5 / 12 SER A 110
GLY A 192
ALA A 191
PHE A 139
ASN A 315
 SER  A 110 (-0.0A)
GLY  A 192 ( 0.0A)
ALA  A 191 ( 0.0A)
PHE  A 139 ( 1.3A)
ASN  A 315 ( 0.6A)
 1.19A 6bqgA-5ep8A:
undetectable		 6bqgA-5ep8A:
9.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CB4_A_BEZA501_0
(CANAVALIN)		 5l5n PLEXIN-A4
(Mus
musculus) 		4 / 8 ASN A 409
LEU A 406
LEU A 397
ILE A 399
 ASN  A 409 ( 0.6A)
LEU  A 406 ( 0.5A)
LEU  A 397 ( 0.5A)
ILE  A 399 ( 0.7A)
 0.92A 6cb4A-5l5nA:
undetectable		 6cb4A-5l5nA:
16.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		 2hk0 D-PSICOSE
3-EPIMERASE
(Agrobacterium
tumefaciens) 		4 / 7 ASP A 275
ASN A 278
ALA A 279
GLU A 212
 ASP  A 275 ( 0.6A)
ASN  A 278 ( 0.6A)
ALA  A 279 ( 0.0A)
GLU  A 212 ( 0.6A)
 0.84A 6ci6A-2hk0A:
undetectable		 6ci6A-2hk0A:
11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DWJ_B_GLYB710_0
(DEOXYNUCLEOSIDE
TRIPHOSPHATE
TRIPHOSPHOHYDROLASE
SAMHD1)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		4 / 5 ARG A 784
GLY A 782
ASN A 781
ASP A 779
 ARG  A 784 ( 0.6A)
GLY  A 782 ( 0.0A)
ASN  A 781 ( 0.6A)
ASP  A 779 ( 0.6A)
 1.38A 6dwjB-1v0fA:
undetectable
6dwjD-1v0fA:
undetectable		 6dwjB-1v0fA:
21.34
6dwjD-1v0fA:
21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DWN_A_AQ4A602_0
(CYTOCHROME P450 1A1)		 4non FERROUS IRON UPTAKE
TRANSPORTER PROTEIN
B
(Streptococcus
thermophilus) 		5 / 12 ASN A   9
LEU A  97
ASN A  84
GLY A  13
ILE A 115
 ASN  A   9 ( 0.6A)
LEU  A  97 ( 0.6A)
ASN  A  84 ( 0.6A)
GLY  A  13 (-0.0A)
ILE  A 115 ( 0.4A)
 1.33A 6dwnA-4nonA:
undetectable		 6dwnA-4nonA:
15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DWN_B_AQ4B602_1
(CYTOCHROME P450 1A1)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		4 / 7 ASN A 406
GLY A  64
ALA A  65
VAL A  79
 ASN  A 406 ( 0.6A)
GLY  A  64 (-0.0A)
ALA  A  65 ( 0.0A)
VAL  A  79 ( 0.6A)
 0.85A 6dwnB-4g9kA:
undetectable		 6dwnB-4g9kA:
10.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_D_ADND502_1
(ADENOSYLHOMOCYSTEINA
SE)		 3qvi HISTO-ASPARTIC
PROTEASE
(Plasmodium
falciparum) 		3 / 3 LEU A 128
ASN A 211
LEU A 184
 LEU  A 128 (-0.6A)
ASN  A 211 ( 0.6A)
LEU  A 184 ( 0.5A)
 0.72A 6exiD-3qviA:
undetectable		 6exiD-3qviA:
10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F32_B_ACTB602_0
(AMINE OXIDASE LKCE)		 3c3n DIHYDROOROTATE
DEHYDROGENASE
(Trypanosoma
cruzi) 		4 / 6 ASN A 234
TYR A 170
VAL A 195
VAL A 198
 ASN  A 234 ( 0.6A)
TYR  A 170 (-1.3A)
VAL  A 195 (-0.6A)
VAL  A 198 ( 0.6A)
 1.27A 6f32B-3c3nA:
undetectable		 6f32B-3c3nA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F32_B_ACTB602_0
(AMINE OXIDASE LKCE)		 4oud TYROSYL-TRNA
SYNTHETASE
(Escherichia
coli) 		5 / 6 ASN B 125
TYR B 127
VAL B 101
VAL B  97
THR B  96
 ASN  B 125 ( 0.6A)
TYR  B 127 ( 1.3A)
VAL  B 101 ( 0.6A)
VAL  B  97 ( 0.6A)
THR  B  96 ( 0.8A)
 1.46A 6f32B-4oudB:
2.9		 6f32B-4oudB:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F32_B_ACTB602_0
(AMINE OXIDASE LKCE)		 5e37 EF-HAND
DOMAIN-CONTAINING
THIOREDOXIN
(Chlamydomonas
reinhardtii) 		4 / 6 ASN A 224
VAL A 260
VAL A 262
THR A 209
 ASN  A 224 ( 0.6A)
VAL  A 260 ( 0.6A)
VAL  A 262 ( 0.5A)
THR  A 209 ( 0.9A)
 1.26A 6f32B-5e37A:
undetectable		 6f32B-5e37A:
22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F7L_B_ACTB505_0
(AMINE OXIDASE LKCE)		 3sag EXOSOME COMPONENT 10
(Homo
sapiens) 		3 / 3 HIS A 264
ASN A 263
LEU A 262
 HIS  A 264 ( 1.0A)
ASN  A 263 ( 0.6A)
LEU  A 262 ( 0.6A)
 0.89A 6f7lB-3sagA:
undetectable		 6f7lB-3sagA:
19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GH9_A_MIXA1003_0
(UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 15)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		4 / 5 ASN A 732
TYR A 325
GLY A 346
HIS A 743
 ASN  A 732 ( 0.6A)
TYR  A 325 ( 1.3A)
GLY  A 346 ( 0.0A)
HIS  A 743 ( 1.0A)
 1.29A 6gh9A-1v0fA:
undetectable		 6gh9A-1v0fA:
10.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNE_A_ACRA602_2
(-)		 2hk0 D-PSICOSE
3-EPIMERASE
(Agrobacterium
tumefaciens) 		4 / 6 TRP A 112
HIS A 186
ASN A 157
GLU A 165
 TRP  A 112 ( 0.5A)
HIS  A 186 ( 1.0A)
ASN  A 157 ( 0.6A)
GLU  A 165 ( 0.6A)
 1.42A 6gneA-2hk0A:
undetectable		 6gneA-2hk0A:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_A_TKTA508_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		4 / 8 ASP A 249
ILE A 246
ARG A 320
ASN A 223
 ASP  A 249 ( 0.6A)
ILE  A 246 ( 0.7A)
ARG  A 320 ( 0.6A)
ASN  A 223 ( 0.6A)
 1.24A 6hisA-3pu5A:
undetectable
6hisB-3pu5A:
undetectable		 6hisA-3pu5A:
13.65
6hisB-3pu5A:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_B_TKTB508_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		4 / 8 ASP A 420
ARG A 398
ARG A 513
ASN A 534
 ASP  A 420 ( 0.6A)
ARG  A 398 ( 0.6A)
ARG  A 513 ( 0.6A)
ASN  A 534 ( 0.6A)
 1.03A 6hisB-1v0fA:
undetectable
6hisC-1v0fA:
undetectable		 6hisB-1v0fA:
8.39
6hisC-1v0fA:
8.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_B_TKTB508_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		4 / 8 ASP A 249
ILE A 246
ARG A 320
ASN A 223
 ASP  A 249 ( 0.6A)
ILE  A 246 ( 0.7A)
ARG  A 320 ( 0.6A)
ASN  A 223 ( 0.6A)
 1.23A 6hisB-3pu5A:
undetectable
6hisC-3pu5A:
undetectable		 6hisB-3pu5A:
13.65
6hisC-3pu5A:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_C_TKTC508_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		4 / 8 ASP A 420
ARG A 398
ARG A 513
ASN A 534
 ASP  A 420 ( 0.6A)
ARG  A 398 ( 0.6A)
ARG  A 513 ( 0.6A)
ASN  A 534 ( 0.6A)
 1.01A 6hisC-1v0fA:
undetectable
6hisD-1v0fA:
undetectable		 6hisC-1v0fA:
8.39
6hisD-1v0fA:
8.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_C_TKTC508_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		4 / 8 ASP A 249
ILE A 246
ARG A 320
ASN A 223
 ASP  A 249 ( 0.6A)
ILE  A 246 ( 0.7A)
ARG  A 320 ( 0.6A)
ASN  A 223 ( 0.6A)
 1.23A 6hisC-3pu5A:
undetectable
6hisD-3pu5A:
undetectable		 6hisC-3pu5A:
13.65
6hisD-3pu5A:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_D_TKTD501_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		4 / 8 ASP A 249
ILE A 246
ARG A 320
ASN A 223
 ASP  A 249 ( 0.6A)
ILE  A 246 ( 0.7A)
ARG  A 320 ( 0.6A)
ASN  A 223 ( 0.6A)
 1.23A 6hisD-3pu5A:
undetectable
6hisE-3pu5A:
undetectable		 6hisD-3pu5A:
13.65
6hisE-3pu5A:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_E_TKTE501_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)		 1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F) 		4 / 8 ASN A 534
ASP A 420
ARG A 398
ARG A 513
 ASN  A 534 ( 0.6A)
ASP  A 420 ( 0.6A)
ARG  A 398 ( 0.6A)
ARG  A 513 ( 0.6A)
 1.01A 6hisA-1v0fA:
undetectable
6hisE-1v0fA:
undetectable		 6hisA-1v0fA:
8.39
6hisE-1v0fA:
8.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_E_TKTE501_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)		 3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN
(Bordetella
parapertussis) 		4 / 8 ASN A 223
ASP A 249
ILE A 246
ARG A 320
 ASN  A 223 ( 0.6A)
ASP  A 249 ( 0.6A)
ILE  A 246 ( 0.7A)
ARG  A 320 ( 0.6A)
 1.23A 6hisA-3pu5A:
undetectable
6hisE-3pu5A:
undetectable		 6hisA-3pu5A:
13.65
6hisE-3pu5A:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HU9_T_PCFT101_0
(CYTOCHROME B-C1
COMPLEX SUBUNIT 1,
MITOCHONDRIAL
CYTOCHROME B-C1
COMPLEX SUBUNIT 9
CYTOCHROME B-C1
COMPLEX SUBUNIT
RIESKE,
MITOCHONDRIAL)		 4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE
(Saccharomyces
cerevisiae) 		5 / 10 SER A 286
MET A 280
GLY A 340
ALA A 178
ASN A 279
 SER  A 286 ( 0.0A)
MET  A 280 ( 0.0A)
GLY  A 340 ( 0.0A)
ALA  A 178 ( 0.0A)
ASN  A 279 ( 0.6A)
 1.35A 6hu9L-4g9kA:
undetectable
6hu9P-4g9kA:
undetectable
6hu9T-4g9kA:
undetectable		 6hu9L-4g9kA:
23.60
6hu9P-4g9kA:
16.74
6hu9T-4g9kA:
11.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HZP_A_FVTA501_0
(PEPTIDE ABC
TRANSPORTER PERMEASE)		 2qc5 STREPTOGRAMIN B
LACTONASE
(Staphylococcus
cohnii) 		4 / 8 ASN A 204
GLN A 247
ILE A 220
GLU A 259
 ASN  A 204 ( 0.6A)
GLN  A 247 ( 0.6A)
ILE  A 220 ( 0.7A)
GLU  A 259 ( 0.6A)
 1.08A 6hzpA-2qc5A:
undetectable		 6hzpA-2qc5A:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6IEY_A_CLMA401_0
(ESTERASE)		 5dne L-ASPARAGINASE
(Cavia
porcellus) 		5 / 11 LEU A 139
HIS A 114
GLY A 115
PHE A 197
ALA A 196
 None
None
ASN  A 601 (-3.2A)
None
None
 1.12A 6ieyA-5dneA:
undetectable
6ieyB-5dneA:
2.5		 6ieyA-5dneA:
19.46
6ieyB-5dneA:
19.46